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CHAPTER I 
 
INTRODUCTION 
 
Intracellular transport 
Transport of proteins and other macromolecules across membrane-
bilayers is essential for all living organisms from bacteria to mammals. To 
achieve this task, cells establish membrane-bound and soluble machines that 
selectively take up or export cellular constituents. This process is essential to 
communicate and adjust to changes in environment. The compartmentalization of 
cellular tasks within membrane-bound intracellular bodies, characteristic of 
eukaryotes, adds an additional layer of complexity to the cell transport apparatus. 
How is the cell able to distinguish proteins and nucleic acids to be directed to 
distinct cellular locales while retaining speed and selectivity? The answer relies 
on the exquisite machines that create transport pathways or channels that 
recognize and translocate macromolecules, the diversity of the signals that 
dictate the final destination of a cargo, and the receptors that facilitate cargo-
channel interactions.  
Newly synthesized proteins or RNAs are directed by transport to different 
sites in the cytosol or within the nucleus, mitochondria, chloroplast, peroxisomes, 
and endoplasmic reticulum (ER). A specialized vesicle-based transport system in 
charge of the internalization, recycling and distribution of proteins and lipids of 
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the secretary pathway also exists (Grosshans et al. 2006; Lee et al. 2004a; 
Mellman and Warren 2000). Proteins and RNAs targeted for transport contain a 
signal sequence that is recognized by the discrete transport machinery of the 
targeted cellular compartment. These sequences are typically encoded in the 
primary sequence of a protein or RNA. However, distant regions of primary 
sequence can form a transport signal through the quaternary structure of a folded 
protein or the secondary structure of an RNA. Protein translocation through the 
ER membrane is dependent on an ER signal sequence often present at the N-
terminus of proteins targeted to the membrane or lumen of the ER (reviewed in 
Rapoport 2007). As ribosomes initiate translation in the cytoplasm, the protruding 
N-terminus of the nascent polypeptide recruits a signal recognition particle 
(SRP).  The SRP directs the ribosome to an SRP receptor in the ER membrane 
to allow directional translocation of the elongating polypeptide chain through the 
Sec61 translocator complex. Similarly, import of proteins to the mitochondrial 
matrix and the stroma in chloroplast depends on an N-terminal signal in the 
primary sequence that interacts with membrane translocators (Baker et al. 2007; 
Kessler and Schnell 2006). Importantly, import into the ER, mitochondria, and 
chloroplast requires the proteins to be unfolded and the signal sequences 
required for the protein import into these organelles are cleaved after the 
completion of transport. This is distinct from nuclear and peroxisomal transport 
that can translocate folded proteins and do not require signal removal. Despite its 
differences, intracellular protein transport studied in all organelles has been found 
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to require, ATP, GTP, or a favorable ion gradient to facilitate translocation (Gould 
and Collins 2002; Koehler 2000; Rapoport 2007; Terry et al. 2007). 
 
Nuclear transport: The Nuclear Pore Complex 
Nuclear transport is different from other types of organellar transport in 
that the transport machinery has to be capable of translocating huge fully folded 
macromolecular complexes, such as ribosomes and other ribonucleoproteins, 
through a double membrane barrier. This represents a formidable task, as these 
cargoes require a large translocation apparatus still capable of selective 
transport. Eukaryotic cells have overcome this problem by assembling a massive 
macromolecular structure to regulate nucleocytoplasmic exchange, the Nuclear 
Pore Complex (NPC). The NPC transverses both layers of the nuclear envelope 
at specific sites called nuclear pores. The NPC is composed of ~30 different 
proteins, called nucleoporins (Nups), and its conserved structure is organized in 
an 8-fold radial symmetry (Figure 1). The NPC serves as the gatekeeper of the 
nucleus by creating an aqueous channel less than 10 nm in diameter that allows 
the free diffusion of only molecules smaller than 25-40 kD (Alber et al. 2007a; 
Alber et al. 2007b; Daneholt 1997; Mattaj and Englmeier 1998). Larger molecules 
must overcome this permeability barrier by interacting directly with the NPC or 
through transport receptors.  
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The structure of the NPC has been shown to be highly conserved by 
three-dimensional cryo-electron microscopy (EM), and tomography (Akey and 
Radermacher 1993; Beck et al. 2004). In Saccharomyces cerevisiae, the NPC is 
predicted to be a ~44 MD structure (Rout et al. 2000). A recent report has 
modeled the yeast NPC by means of computational integration of biochemical 
and biophysical data (Alber et al. 2007a; Alber et al. 2007b). The resulting model 
(Figure 1) reveals a macromolecular assembly in which each of the eight pillars 
of the NPC is divided in two columns. The backbone of the NPC is thought to 
interact with the nuclear membrane and be the point of anchor for flexible protein 
extensions that stretch towards the center of the channel. These proteinaceous 
extensions are highly enriched in phenylalanine - glycine (FG) repeats and 
constitute the bulk of the NPC permeability barrier (Terry et al. 2007). 
The mechanistic details of selective transport through the NPC 
permeability barrier is a highly debated topic (Frey et al. 2006; Lim et al. 2006; 
Macara 2001; Ribbeck and Gorlich 2002; Rout et al. 2003; Strawn et al. 2004; 
Terry and Wente 2007). It is agreed, however, that FG-domains play a critical 
role in establishing the selectivity of the translocation process by interacting with 
transport receptors. The affinity gradient model proposes that FG-domains 
establish a path of increasing affinity binding sites for transport receptors from 
one side of the NPC to the other (Ben-Efraim and Gerace 2001). This simple 
model accounts for directionality of transport but cannot be reconciled with 
observations showing that FG-domains at the cytoplasmic and nucleoplasmic 
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side of the NPC are not essential (Strawn et al. 2004) and can be exchanged 
(Zeitler and Weis 2004). The Brownian affinity gating model (Rout et al. 2000) 
suggests that interaction with FG-domains at the NPC increases the local 
concentration of transport receptors and overcomes the entropic barrier 
established by the narrow NPC channel. Translocation through the NPC is then 
mediated by Brownian random diffusion. The oily spaghetti model (Macara 2001) 
suggests that flexible FG-domains are pushed aside by transport receptors. 
Similar to the Brownian affinity gating model, transient association with FG’s 
receptors and random motion allows translocation. Finally, the selective phase 
model (Frey and Gorlich 2007; Ribbeck and Gorlich 2001), based on hydrophobic 
interactions between FG-domains, proposes that a gel-like FG-meshwork is 
formed at the NPC channel. Receptor binding to the FG domains melts the 
meshwork locally, allowing reformation of the phase as the receptor travels 
through the NPC channel. This model accounts for selectivity of the transport 
process. However, this model is based on biophysical and biochemical 
observations under unphysiological conditions. The models proposed will have to 
take into consideration the speed and cargo capacity of the NPC, estimated to 
translocate up to 10 molecules simultaneously and transport ~1000 molecules 
per second (Ribbeck and Gorlich 2001) (Yang et al. 2004).  
Interestingly, the translocation apparatus must accommodate multiple 
kinds of cargoes. In fact, distinct FG-domains seem to be required for specific 
transport receptors (Terry and Wente 2007). Similarly, it is important to 
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emphasize that the NPC is not an static structure. In fact, the NPC might 
reorganize to allow the passage of fully folded-membrane proteins to the inner 
nuclear membrane (Lusk et al. 2007). Additionally, metazoans must dismantle 
their NPCs during each cell division; a process that is only partially done in A. 
nidulans, and absent in budding yeast. How is a gel-like network made out of FG-
domains disassembled and reassembled during mitosis? How is the permeability 
barrier affected during a closed mitosis? Strikingly, the mammalian NPCs seems 
to have an intrinsic ability to increase their diameter by intramolecular sliding of 
core NPC backbone components (Melcak et al. 2007), an attribute that could 
facilitate the transport of oversized cargo. To conclude, further modeling and 
testing in vivo is required to test proposed models and to tackle outstanding 
questions in the field regarding NPC assembly, the nature of the permeability 
barrier, transport of large cargoes, differential regulation of NPCs within a given 
cell, and establishment of directionality. 
Great advances on classical protein nuclear import have been achieved, 
partly through the development of in vitro transport assays. Directional protein 
translocation is achieved by the asymmetric distribution of the small GTPase Ran 
in its GTP- and GDP-bound forms (Fried and Kutay 2003; Figure 2). The 
chromatin-associated Ran-specific guanine exchange factor (RanGEF) maintains 
a steady pool of RanGTP in the nuclear environment, whereas the Ran-specific 
GTPase activating protein (RanGAP) sustains GTP hydrolysis in the cytoplasm, 
keeping high cytoplasmic-RanGDP levels. The nuclear protein  
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transport machinery, composed of soluble karyopherins (also known as 
transportins, exportins, and importins), recognizes the RanGTP/GDP gradient, 
binds signal-containing cargoes, and interacts with NPC components to establish 
the directionality of transport. In the case of protein export, a nuclear export 
signal (NES) is recognized by nuclear export receptor CRM1/Xpo1 (Stade et al. 
1997) in a RanGTP-dependent fashion (Fried and Kutay 2003). This complex 
binds and traverses the NPC.  Disassembly in the cytoplasm is mediated by 
structural rearrangements in Ran resulting from GTP hydrolysis (Gamblin and 
Smerdon 1999) stimulated by cytoplasmic RanGAP. RanGDP is imported into the 
nucleus, where it exchanges the GDP for a GTP. In the case of nuclear protein 
import, a nuclear localization signal (NLS) is recognized by an importin. Importin-
cargo complexes bind FG-domain and translocate through the NPC. Once in the 
nucleus, RanGTP disrupts importin-cargo interactions to finalize the import 
process (Fried and Kutay 2003). In this fashion, Ran plays the role of a molecular 
switch controlled by local regulation of GTP exchange and hydrolysis. tRNA, 
microRNA, small nuclear RNA, and ribosomal RNA export are exported utilizing a 
RanGTP/GDP gradient (Kohler and Hurt 2007). A new paradigm, however, 
seems to drive mRNA export, and the work presented here seeks to illuminate 
this novel mechanism. First, an overview of mRNA metabolism and the body 
knowledge acquired by studies in yeast and metazoans is presented. 
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mRNA: From birth to export 
The nuclear export of mRNAs to the cytoplasm is tightly linked to 
transcription, processing, quality control, translation and degradation (Figure 3). 
Each of the steps in the life of a mRNA is regulated by a host of protein and RNA 
factors that facilitate intra- or intermolecular reactions. Consequently, it is crucial 
to picture mRNAs in the context of a dynamic messenger ribonucleoprotein 
particle (mRNP). The mRNP is born at the doorsteps of polymerase II (Pol II)-
driven transcription, where the protruding mRNA recruits proteins as soon as ~20 
nucleotide have been transcribed (Bentley 2005; Gu and Lima 2005). From that 
point onward, the mRNP experiences dramatic changes recruiting proteins 
required for capping, splicing, mRNA export, translation, and degradation 
(Buratowski 2005; Fasken and Corbett 2005; Jensen et al. 2003; Vinciguerra and 
Stutz 2004)  
pre-mRNAs are transcribed by Pol II-driven transcription. The forming pre-
mRNA is extruded through the Pol II exit channel at the rate of 10-30 bases per 
second (Bentley 2005). However, the role of Pol II is not limited to regulation of 
transcription. The C-terminal domain (CTD) of Pol II recruits a number or mRNA 
processing factors that bind the mRNA co-transcriptionally, facilitating mRNP 
formation. Interestingly, these same factors seem to have a positive impact on 
the transcription process.  
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 The first step in mRNA processing is the capping of the 5’ end. In capping, 
the 5’ terminal phosphate is cleaved and a GMP nucleotide is linked by a 5’-5’ 
triphosphate bridge to produce GpppN. Subsequently, the G is methylated at the  
N7 position, and this m7G constitutes the cap (Shatkin 1976). These reactions 
take place as the Pol II pauses and the capping enzymes bound to the CTD of 
Pol II interact with the 5’ end of the protruding message (Sims et al. 2004). The 5’ 
cap then recruits a cap-binding complex (CBC) that is able to interact with 
multiple other factors important for gene expression. Capping of the mRNA is 
thought to stabilize the mRNA and have roles in 3’ end formation, and translation 
(Cheng et al. 2006; Lewis and Izaurralde 1997).  
Next, the mRNA undergoes splicing, a process in which introns are 
removed and exons are joined in the primary sequence of a mRNA. Splicing sites 
are marked by three sequences in exons and introns that direct the splicing 
reaction and define the branch site, splicing donor and splicing acceptor. These 
sequences also determine splicing efficiencies that can give rise to alternative 
splicing. The splicing machinery is deposited at splice sites co-transcriptionally in 
every intron, however, intron excision can occur either co- or post-
transcriptionally within the same transcript (Wetterberg et al. 1996; Wetterberg et 
al. 2001). Splicing radically alters the fate of a mRNA molecule. In addition to the 
changes in protein coding information, the splicing machinery deposits a protein 
complex in the vicinity of exon-exon junctions (Isken and Maquat 2007). The 
exon-exon junction complexes (EJCs) mark the sites of intron excision, a label 
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that is thought to be critical to avoid the mRNA degradation machinery that 
targets unspliced and aberrant messages.  
Transcription of the 3’ end of a pre-mRNA is followed by 3’ end cleavage 
and poly(A) addition to the newly formed 3’ hydroxyl group. Protein complexes 
that recognize primary sequences upstream and downstream of the cleavage site 
are first associated with the CTD and then transferred to the mRNA as it emerges 
from Pol II (Gilmartin 2005). Once synthesized, poly(A) tails are recognized by 
the poly(A) binding proteins. In the yeast nucleus, Nab2 and Pab1 are thought to 
be the potential poly(A) binding proteins (Dunn et al. 2005; Green et al. 2002; 
Marfatia et al. 2003). Addition of poly(A) tails is thought to play important roles in 
mRNP release from sites of transcription, mRNA export, translation, and stability 
(Gilmartin 2005). In fact, protein-protein interactions have been detected between 
poly(A) binding proteins and the CBC, the mRNA export machinery, and the 
cytoplasmic mRNA decay systems.  
 By the end of mRNA processing, a mature mRNP will have a 5’ cap, 
followed by the 5’ UTR, coding sequence marked with EJCs, an in-frame stop 
codon, a 3’ UTR, and a poly(A) tail. Additionally, a mRNA will be decorated with a 
host of proteins recruited during processing like the CBC, EJC, and poly(A) 
binding proteins. Together this cohort of proteins and mRNA constitute the export 
competent mRNP. Some of these proteins, important in export and translation, 
will be discussed in the next section. Importantly, the cell employs several quality 
control or surveillance mechanisms to ensure that only properly processed 
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mRNPs are utilized by the translation machinery.  Some of these mechanisms 
reside in the nucleus whereas others work in the cytoplasm.  
Nuclear degradation of mRNA can go from 5’-3’ or vice versa. 3’-5’ 
degradation is carried out by the nuclear exosome, whereas the 5’-3’ is mediated 
by the Rat1 exoribonuclease (Libri et al. 2002; Rosonina et al. 2006). For 
degradation to proceed, caps and poly(A) tails must be removed. If a message is 
not capped, the exposed 5’ end is recognized by Rat1 and the message is 
degraded (Kim et al. 2004). In yeast, splicing mutants give rise to an increase of 
pre-mRNAs. These mRNAs are stabilized by mutations in genes encoding 
proteins of the nuclear exosome (Bousquet-Antonelli et al. 2000), suggesting that 
the cell is able to target these messages for degradation through the nuclear 
exosome. An additional surveillance mechanism is provided by the NPC-
associated Mlp1 and Mlp2 proteins that retain unspliced messages at the NPC 
(Galy et al. 2004). Since these proteins mark the gate of the NPC, it is argued 
that the NPC scrutinizes the mRNPs allowing only the exit of properly processed 
messages.  
  
Nuclear export of mRNA 
In essence, mRNA export follows the classical paradigm of intracellular 
transport. Namely, the mRNA is recognized by an export receptor that interacts 
with the transport channel (the NPC) to facilitate translocation. However, the 
interconnectivity between transcription, processing, and export makes it  
 15 
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impossible to isolate mRNA export as a single simple mechanism. Additionally, 
translocation of large macromolecular complexes, such as mRNPs, through the 
NPC requires dynamic changes in the composition and structure of the cargo. 
For instance, EM studies of the giant insect mRNP known as the Balbiani ring 
revealed a dramatic relaxation in mRNP structure upon NPC docking (Mehlin et 
al. 1992). Finally, mRNA export feeds directly into translation, and recent data 
suggest a tight communication between these two processes. How is the mRNP 
recruited to the NPC? What are the biochemical requirements for mRNP 
remodeling? How is the mRNP released in the cytoplasm for translation?  
One of the most informative observations in the mRNA export field have 
come form direct visualization of the electron dense Balbiani ring by EM 
(Daneholt 2001a, b; Mehlin et al. 1992). These observations suggest that 
remodeling events allow the straightening and correct orientation of the mRNP, 
which is extruded in a 5’ to 3’ direction (Figure 4 A-B). Furthermore, whereas 
some proteins are recruited co-transcriptionally and stay associated with the 
mRNP during specific processing steps and translation, others are only 
transiently associated with the message.  
Export of mRNA is mediated by the conserved mRNA export receptor 
Mex67 (Figure 5). The yeast Mex67 functions with Mtr2 as a heterodimer 
(TAP/NXF1-p15/NXT1 in metazoans) and represents a novel class of export 
receptors distinctive from the karyopherin family in sequence and structure 
(Gruter et al. 1998; Segref et al. 1997). Additionally, Mex67-driven export is not  
 17 
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regulated by Ran cycles of GTP hydrolysis. Nevertheless, Mex67 shares many of 
the properties of nuclear exporters of the karyopherin class. This includes 
interaction with FG domains, ability to overcome the NPC permeability barrier, 
and recycling back to the nucleus for subsequent rounds of export.  
Association of Mex67 with the mRNP is considered to be an essential step 
during the mRNA export process. Accordingly, the eukaryotic cell has created 
several mechanisms to guarantee this step. Mex67 is recruited to the mRNA 
cotranscriptionally by its physical association to the yeast SR protein Npl3 
(Gilbert and Guthrie 2004). Initially, Npl3 associates with the nascent mRNA in a 
phosphorylated state (Gilbert et al. 2001). Npl3 dephosphorylation stimulates the 
recruitment of Mex67, facilitating mRNP export. Once in the cytoplasm, re-
phosphorylation of Npl3 destabilizes its interaction with Mex67 (Gilbert et al. 
2001). In mammals, TAP/NXF1 recruitment is also regulated by phosphorylation 
cycles of SR-proteins (Huang et al. 2003). However, unlike its yeast counterparts, 
mammalian SR-proteins regulate splicing, and load TAP/NXF1 during this step. 
An alternative or complementary route for Mex67 recruitment is provided by Yra1 
(ALY/REF in metazoans), which is itself, recruited to activated genes (Lei et al. 
2001). In fact, Yra1 is part of the transcription/export (TREX) complex, which has 
multiple roles during transcription and mRNP formation (Strasser et al. 2002; 
Zenklusen et al. 2001).  
To sum up, the multiple roles of mRNP proteins in transcription, 
processing, and export are conveniently intertwined to facilitate the flow of the 
 19 
mRNP maturation process and provide communication between these multiple 
steps. An export competent mRNP containing Mex67 is targeted for translocation 
through the NPC. FG-domains within the NPC channel are able to bind Mex67 
and facilitate mRNP translocation. Interestingly recent studies in vivo suggest 
that Mex67-containing mRNPs interact with distinct FG-nucleoporins (Terry and 
Wente 2007), suggesting specialized pathways within the NPC for mRNA export.  
 
Gle1 and Dbp5: Conserved mRNA export factors 
Release of the mRNP in the cytoplasm is thought to be mediated by Dbp5, 
a member of the conserved DEAD-box helicase family (Cordin et al. 2006; Linder 
2006). Moreover, Dbp5 is thought to remodel the mRNP by dissociating a subset 
of RNA binding proteins from the mRNP (Lund and Guthrie 2005; Tran 2007). 
Since Nup159 provides a Dbp5 binding site at the cytoplasmic side of the NPC 
(Figure 6) (Schmitt et al. 1999; Weirich et al. 2004), Dbp5 has been suggested to 
remodel the mRNP for regulation of later stages of mRNA export.Consistent with 
this model, mutations in DBP5 result in strong poly(A)+ mRNA accumulation in 
the nucleus at non-permissive temperatures (Snay-Hodge et al. 1998; Tseng et 
al. 1998). These stalled mRNPs have been found to contain Mex67 (Lund and 
Guthrie 2005). Importantly, a mutation in MEX67 is able to rescue both the 
Mex67-5 accumulation and growth defect of a dbp5 strain; suggesting Mex67  
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dissociation is facilitated by Dbp5. Importantly, a recent study has reported a role 
for Dbp5 in translation (Gross et al. 2007). This exciting finding expands our view  
of interconnected regulation of gene expression, revealing yet another 
mechanism with intimate ties to the mRNA export machinery.  
Regulation of the final steps in mRNA export has also been attributed to 
the novel and conserved mRNA export factor Gle1 (human (h)Gle1A or B in 
mammals) (Murphy and Wente 1996; Watkins et al. 1998; Figure 6). Gle1 was 
originally isolated in a NUP100 synthetic lethal screen. The resulting gle1 
temperature sensitive alleles show a strong mRNA accumulation in the nucleus. 
Additional studies have identified interactions between Gle1 and mRNA export 
components. Pull downs utilizing in vitro transcription translation and yeast-two-
hybrid studies have demonstrated that Gle1 binds Dbp5 (Hodge et al. 1999; 
Schmitt et al. 1999; Strahm et al. 1999). Additionally, Gle1 has been found to 
interact with Gfd1 (Hodge et al. 1999; Strahm et al. 1999; Suntharalingam et al. 
2004), a factor with physical and genetic interactions with Dbp5 and Nab2. 
Nup42, a nucleoporin localized at the cytoplasmic face of the NPC, provides a 
binding site for Gle1 (Murphy and Wente 1996; Figure 6), an interaction 
conserved in metazoans (Kendirgi et al. 2005). The genetic and physical data 
gathered strongly suggest a role for Gle1 in the later stages of mRNA export and 
release. Consistent with this hypothesis, immuno-EM studies have shown that 
Gle1 localizes more predominantly at cytoplasmic side of the NPC (Miller 2004; 
Rout et al. 2000). Interestingly, in humans a splice variant results in the 
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expression of two Gle1 isoforms, hGle1A and hGle1B. hGle1B is the most 
abundant isoform in the cell. Importantly, it contains an additional 43-amino acid 
yeast-Gle1 (yGle1)-like domain at its C-terminus that mediates NPC binding 
through hCG1 (the human homologue of Nup42). hGle1 has also been found to 
interact with hNup155 (Rayala et al. 2004), but this interaction is not sufficient for 
NPC recruitment. Additionally, hGle1 contains a shuttling domain not conserved 
in yGle1 that plays a role for mRNA export (Kendirgi et al. 2003). It is unclear 
whether both hGle1B and hGle1A have complementary roles in mRNA export 
and whether yGle1 can shuttle like its human homologue. Due to the high 
sequence similarity between yeast and human Gle1 proteins, they are expected 
to have similar roles in mRNA export.  
Genetic studies in yeast have identified components of the inositol 
signaling pathway that gives rise to the production of inositol hexakisphosphate 
(IP6) as important players in the Gle1-driven step in mRNA export (York et al. 
1999). In wildtype (wt) cells, production of soluble inositols is not essential. 
However, cells harboring temperature sensitive mutations in gle1 or dbp5 are 
unable to survive if IP6 levels are reduced (Miller 2004; York et al. 1999). 
Additionally, lack of IP6 production has detrimental effects on growth of cells with 
mutations in NUP42, NUP159, NUP116, and GLE2, genes encoding proteins 
localized at the cytoplasmic side of the NPC. Importantly, yeast cells unable to 
produce IP6 have a weak poly(A)-mRNA accumulation at 37 ˚C. What is the role 
of IP6 in mRNA export? What is its biochemical target?  
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The field has gained important insights into the mechanism of mRNA 
export. Of great importance is the discovery of a physical link between the 
transcription and processing machineries with export receptors and the NPC 
itself, a phenomenon called gene gating (Blobel, 1985). However, little is known 
about the later stages of mRNA export at the cytoplasmic face of the NPC. 
Furthermore, a recent report providing a link between mRNA export and 
translation has extended the field and suggest a role for Dbp5 in both processes. 
The work presented here seeks to elucidate the mechanisms of mRNA export at 
the cytoplasmic face of the NPC. Specifically, it seeks to unveil the precise roles 
of Gle1 and IP6 at the later stages of mRNA export.  
It has been known that soluble inositols represent versatile intracellular 
second messengers with multiple roles in gene expression (see below). 
However, the understanding of how they regulate cellular physiology is still in its 
infancy. In order to understand IP6, and its potential regulation of mRNA export, it 
is important to review the roles of other inositols polyphosphates (IPs) in cell 
physiology. Recent advances in the inositol-signaling field have underlined the 
importance of these molecules and are reviewed below.  
 
The IP signaling pathway 
Inositol was first identified more than a century and a half ago by the 
German chemist Josef Scherer (Scherer 1850, 1851) who isolated it from muscle 
tissue and coined the new molecule inos (Greek for muscle). We now find that  
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the study of soluble and membrane-bound inositols, referred to as inositides, has 
intersected almost every aspect of cellular biology. Of the nine possible isomers 
of inositol, myo-inositol is the most abundant in nature (Kersting et al. 2003) with 
the six-carbon ring harboring one axial hydroxyl at the D-2 position and five 
equatorial hydroxyl groups (Figure 7). Building on this structure, a great diversity 
of inositol derivatives is achieved with multiple combinations of mono- and pyro-
phosphate groups attached to each of the six hydroxyls moieties. Additional 
molecular complexity is accomplished by the potential incorporation of these 
derivatives in lipid head groups. To date, more than 37 distinct inositides have 
been identified in biological systems  (Irvine 2005; York 2006), and it is likely that 
future work will discover additional inositol molecules with important physiological 
roles. The cytoplasmic functions of the lipid-anchored inositides, referred to as 
inositol lipids, phosphoinositides, or phosphatidylinositols (PIPs), have been 
reviewed in depth (Strahl and Thorner 2007) and include essential structural and 
signaling roles in vesicular trafficking, actin cytoskeleton rearrangements, and Akt 
signaling. On the other hand, soluble phosphoinositides, referred to as IPs have 
been found to have roles in nuclear processes especially in gene expression. 
Many of these physiological breakthroughs have been reported in the context of 
the budding yeast Saccharomyces cerevisiae model system. Importantly, recent 
key advances have identified long-sought kinases and elucidated molecular 
targets of IPs. 
 
 26 
The metabolic machinery for soluble IPs 
Inositol is essential for the life of a eukaryotic cell. However, its origin does 
not seem to be eukaryotic because myo-inositol derivatives have been found in 
archaea and some prokaryotes (Krings et al. 2006; Michell 2007). It is tempting 
then to speculate that inositol-generating enzymes evolved before the 
appearance of eukaryotes (reviewed in (Irvine 2005; Michell 2007), with the 
entire armada of kinases, phosphatases, and other inositol-metabolizing 
enzymes emerging thereafter. S. cerevisiae requires one of two mechanisms to 
acquire inositol; uptake of inositol molecules from the extracellular media by 
inositol-specific transporters or conversion of glucose-6-phosphate (G-6-P) to 
inositol-3-phosphate through the enzymatic activity of inositol-l-phosphate 
synthase (Ino1). Itr1 and Itr2 are yeast inositol permeases with high homology to 
the sugar transporter superfamily (Nikawa et al. 1991). Inositol uptake is 
completely abolished in yeast cells that lack both the Itr1 and Itr2 transporters, 
suggesting that they represent the only route for inositol uptake into the cell. Not 
surprisingly, yeast cells maintain inositol homeostasis by altering transcription, 
localization, and stability of Itr1, Itr2, and Ino1 during differential growth demands 
and availability of extracellular inositol (Lai and McGraw 1994; Nikawa et al. 
1993) (Robinson et al. 1996). In mammalian cells, de novo production of inositol 
also relies on G-6-P conversion to inositol-3-phosphate by the highly conserved 
INO/MIP synthase (Guan et al. 2003; Ju et al. 2004). Additionally, inositol is 
transported via H+ myo-inositol cotransporter and sodium–myo-inositol 
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cotransporter 1/2, respectively (Coady et al. 2002; Kwon et al. 1992; Uldry et al. 
2001), which uptake inositol from serum levels that range from 30 to 70 µM 
(Dolhofer and Wieland 1987; Kouzuma et al. 2001; MacGregor and Matschinsky 
1984). Once in the cytoplasm, inositol is available for incorporation into lipids and 
subject to multiple rounds of phosphorylation and subsequent dephosphorylation. 
This process results in a diverse collection of lipid-anchored PIPs. 
IP signaling depends entirely on the hydrolysis of phosphatidylinositol 4,5-
bisphosphate (PIP2) by members of the phospholipase-C (PLC) family. In 
budding yeast, this reaction is carried out by Plc1 (Flick and Thorner 1993; Payne 
and Fitzgerald-Hayes 1993; Yoko-o et al. 1993). Such hydrolysis results in the 
generation of membrane-bound diacylglyercol (DAG) and the release of inositol 
1,4,5-trisphosphate (IP3). This IP3 serves as the backbone for the formation of all 
other IPs in yeast and metazoans (Figure 8). 
The conversion of IP3 to all other IPs is mediated by specific inositol 
kinases and phosphatases. A simplified chart depicting the main mammalian and 
fungal inositol metabolic pathways is presented in Figure 8. In budding yeast, 
Plc1-mediated release of IP3 is the rate-limiting step for the production of inositol 
hexakisphosphate (IP6), the fully monophosphorylated inositol species. The 
framework for the kinase pathway was built on the discovery of the genes 
encoding the IP kinases Ipk1 and Ipk2 in a budding yeast genetic screen  
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studying mRNA export (York et al. 1999). The IP6-5-kinase Kcs1 (Saiardi et al. 
1999) and the recently identified IP6-4/6 kinase Vip1 (Mulugu et al. 2007) are 
responsible for the production of a number of pyrophosphorylated IP isoforms, 
designated inositol pyrophosphates (IPPs). An alternative low-abundance IP 
pathway has been reported relying on the IP3 3-kinase (ITPK) activities of yeast 
Ipk2 and mammalian ITPKs Itpka, Itpkb, Itpkc and inositol phosphate multikinase 
IPMK (omitted in Figure 8 for simplicity; (Frederick et al. 2005; Leyman et al. 
2007; Seeds et al. 2005). In mammals, the inositol metabolic pathway is more 
complex and involves both a yeast-like pathway driven by Ipk2/inositol 
multikinase (IPMK) and an alternative pathway driven by isomerization of 
I(1,4,5)P3 to I(1,3,4)P3 and two subsequent rounds of phosphorylation by 
I(1,3,4)P3 5/6-kinase (Verbsky et al. 2005b) to form inositol (1,3,4,5,6) 
pentakisphosphate (IP5). Strikingly, both yeast and mammals utilize the same IP5 
isomer and conserved Ipk1 enzymes for the formation of IP6, the linchpin for 
multiple higher pyrophosphorylated IPs. 
 
Cellular logistics of the IPs 
The molecular diversity of the myo-inositol derivatives and their ubiquitous 
presence is equally matched in scope by the range of their cellular abundances 
across species and cell types. IP6, is the major form of phosphorus in plant seeds 
and accounts for ~1% of a typical seed’s dry weight (Raboy 1997). Similarly, in 
the budding yeast, IP6 levels are at much higher concentrations than IP3, inositol 
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(1,3,4,5) tetrakisphosphate (IP4), and IP5 (York et al. 1999). Mammalian IP6 levels 
range from 10 to 100 µM (Bunce et al. 1993; French et al. 1991; Pittet et al. 1989; 
Szwergold et al. 1987), and in many cases, cells accumulate IP5 to similar levels 
as IP6 (Bunce et al. 1993; Feng et al. 2001; Frederick et al. 2005; Glennon and 
Shears 1993; Verbsky et al. 2005a). In contrast, in zebrafish embryos, IP3 is the 
predominant steady-state isoform with relative IP6 levels below detection 
(Sarmah et al. 2005). This suggests different functional roles for the IPs in distinct 
species and suggests that there are potentially novel regulatory mechanisms that 
control the respective IP levels. 
Many biological processes are regulated not only by the production and 
abundance of its constituents but also by spatial–temporal constraints. The 
inositol-signaling pathway likely follows this paradigm. A classical view of Plc1 
places it on the plasma membrane, restricting PIP2 hydrolysis activity in the 
cytoplasm. It is now evident that PIP2 and Plc1 are present both at the plasma 
membrane and in the nucleus in yeast and mammals (Audhya and Emr 2003; 
Cocco et al. 1998; Martelli et al. 1992; Strahl and Thorner 2007). In fact, Plc1 
shuttles between the nucleus and cytoplasm (Strahl and Thorner 2007). With 
both substrate and enzyme at both locales, it is possible that Plc1 localization 
and activity is regulated and that the distinct pools of IP3 are released in the 
nucleus and cytoplasm with different fates and physiological roles. 
A number of IP-metabolizing enzymes localize primarily to the nucleus or 
nuclear periphery in budding yeast cells (Table 1). This observation complements  
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Table 1: Subcellular localization of the inositide metabolic machinery 
leading to nuclear IPs in S. cerevisiae 
 
Protein Function Products Localization References 
Itr1 Inositol transport - Plasma membrane Miyashita et al. 2003 
 
Itr2 Inositol transport - Plasma membrane Miyashita et al. 2003 
 
Ino1 IP synthase IP Cytoplasmic Culbertson and Henry 1975; 
Huh et al. 2003 
 
Inm1 Inositol phosphatase I Nucleus/cytoplasm Huh et al. 2003; Murray and 
Greenberg 1997 
 
Pis1 PI synthase PI ER Huh et al. 2003; Nikawa and 
Yamashita 1982 
 
Pik1 PI kinase PIP Nucleus/cytoplasm Flanagan and Thorner 1992; 
Strahl et al. 2005 
 
Mss4 PIP kinase PIP2 Nucleus/cytoplasm Audhya and Emr 2003 
 
Plc1 PIP2  phospholipase IP3 Nucleus/cytoplasm Strahl and Thorner 2007 
 
Ipk2 IP3/IP4 kinase IP4; IP5 Nucleus El Bakkoury et al. 2000; Odom 
et al. 2000 
 
Ipk1 IP5 Kinase IP6 Nuclear Periphery York et al. 1999 
 
Kcs1 IP5/IP6/IP7 5-kinase PP-IP4; IP7; 
IP8 
Nucleus/cytoplasm Luo et al. 2002  
 
Vip1 IP6/IP7 4/6-kinase IP7; IP8 Nucleus/cytoplasm Huh et al. 2003; Mulugu et al. 
2007 
 
Ddp1* IPP phosphatases IP5; IP6 Nucleus/cytoplasm Huh et al. 2003; Safrany et al. 
1999 
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the increasing diversity of IP roles reported in nuclear processes (see below). 
Table 1 summarizes the subcellular localizations of reported yeast IPs 
transporters, kinases, and phosphatases leading to nuclear IPs. Despite the 
wealth of information available on the localization of inositol-metabolizing 
enzymes, one fundamental question of inositol physiology has remained 
unanswered: Where are the IPs themselves localized? In mammalian cells, it is 
known that IP3 released from the plasma membrane can diffuse through the 
cytoplasm and activate IP3 receptors localized in the endoplasmic reticulum 
membrane (Foskett et al. 2007). Studies in HL60 promyeloid cells suggest that 
IPs have free access to the cytoplasm as plasma membrane-permeabilized cells 
do not retain their IPs (Stuart et al. 1994). Similarly, at least some yeast IPs can 
diffuse from their sites of production. The yeast Ipk1 enzyme, responsible for the 
generation of IP6, is localized at the nuclear periphery (York et al. 1999); 
however, when Ipk1 is artificially anchored to the plasma membrane, IP6 is 
generated and able to reach its target at the NPC and facilitate mRNA export 
(Miller 2004). Thus, free exchange and diffusion through the cytoplasm might be 
a universal characteristic of IPs. A more fascinating alternative would be that 
some IPs are restricted to specific cellular structures or regions, having access to 
only a subset of targets. Plants seeds, for example, compartmentalize IP6 in 
membrane-bound structures called protein storage vacuoles, albeit, as salts of 
mineral cations (Otegui et al. 2002). Additionally, IP6 has been suggested to bind 
membranes utilizing Ca2+or Mg2+ ions possibly through interactions with 
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phospholipids (Poyner et al. 1993). Direct observation of the dynamic IP 
localization in vivo through the development of fluorescent dyes or protein probes 
would undoubtedly help resolve this issue and should be a goal for future studies.  
 
IP protein recognition domains 
The great variety of IPs generated by the metabolic machinery, taken 
together with their diverse roles, suggests the presence of an exquisite system 
that differentiates between mono- and pyro-phosphorylated forms of IPs in their 
different stereoisomeric forms. Recent structural data reveal that no single 
general fold is employed by IP-binding proteins. The reported IP-bound 
structures are grouped in two categories: IP-kinases and IP-binding proteins. 
 
IP kinases 
Based on the high-resolution protein structures available and sequence 
homologies, the characterized IP kinases can be subgrouped into three main 
families: the inositol 5/6-kinases, the inositol 2-kinases, and the IPKs. The IPK 
group can be further divided into 3-kinases, IPMKs, and IP6 kinases (Holmes and 
Jogl 2006; Miller et al. 2005). To date, high-resolution structures have been 
reported for the mammalian I(1,4,5)P3 3-kinase (Chamberlain et al. 2005; 
Gonzalez et al. 2004; Miller and Hurley 2004), the Entamoeba histolytica (Miller 
et al. 2005) and mammalian(Chamberlain et al. 2005) I(1,3,4)P3 5/6-kinases, 
(Miller et al. 2005) and the budding yeast I(1,4,5)P3 3/6-kinase Ipk2 (Holmes and 
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Jogl 2006). A structure for an IP5 2-kinases family member has not been 
completed. 
Analysis of both the I(1,4,5)P3 3-kinase and I(1,3,4)P3 5/6-kinases reveals 
structurally distinct conformations. The overall fold of the I(1,4,5)P3 3-kinase is 
very similar to lipid and protein kinases, especially in the catalytic amino and 
carboxyl domains (Gonzalez et al. 2004). On the other hand, the I(1,3,4)P3 5/6-
kinase shows striking similarity to the ATP-grasp fold proteins (Cheek et al. 2002; 
Miller et al. 2005). For both the I(1,4,5)P3 3-kinase and I(1,3,4)P3 5/6-kinase, 
predominant lysine, arginine, and histidine residues form a positively charged 
pocket wherein the respective IP binds. IP recognition is achieved by direct 
binding to the phosphate rather than the hydroxyl groups. It is interesting to note 
that constrictions in the active site of both structures suggest specific physical 
determinants that elucidate the absence of activity on lipid phosphatidylinositides. 
The recently solved X-ray crystallography structure for the yeast Ipk2 
shows similarity to the I(1,4,5)P3 3-kinase, confirming a conservation of folds in 
the IPK family (Holmes and Jogl 2006). It is interesting to note that Ipk2 
recognizes and phosphorylates both IP3 and IP4 (Odom et al. 2000); (Saiardi et 
al. 1999). The Ipk2 structure reveals an active site that presumably would allow 
IPs in several possible orientations. This suggests a potential mechanism by 
which multiple IP substrates are accommodated (Holmes and Jogl 2006), a 
prominent characteristic for some IPKs in vitro and in vivo (Miller and Hurley 
2004). Importantly, rat IPMK has been shown to be a highly specific PI(4,5)P2 3-
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kinase in vitro, and its overexpression increases PI(3,4,5)P3 levels in vivo 
(Resnick et al. 2005). This dual lipid and soluble inositol kinases capacity might 
be attributed to key differences in the inositol-binding domains of I(1,4,5)P3 3-
kinases and Ipk2, the latter containing two of the five alpha-helices present in 
I(1,4,5)P3 3-kinases (Holmes and Jogl 2006). 
 
IP-binding proteins 
Several IP-binding proteins have also been recently cocrystallized with 
their respective IPs (Bosanac et al. 2002; Macbeth et al. 2005) (Milano et al. 
2006; Tan et al. 2007). In all reported cases, the IP-binding site is formed by the 
clustered localization of basic amino acid residues in a three-dimensional pocket. 
This is similar to the IP kinases. However, in contrast, these basic lysine and 
arginine residues do not fall into a defined motif. Rather, they are dispersed 
through a ~200–300-amino acid region of the particular protein’s primary 
sequence. Importantly, the solved IP-binding targets also fold in completely 
unrelated domains that lack sequence or structural similarities. For these 
reasons, an easily identifiable IP-binding motif has not been resolved, and there 
is currently no bioinformatic approach available to the search for novel IP-binding 
proteins. However, the basic residues are presumably critical for IP binding as 
shown in mutant studies of the tetrameric IP3 receptor (Yoshikawa et al. 1996). 
Overall, the protein targets clearly recognize the specific phosphorylation state of 
the inositol ring and different isomeric forms. In the future, new structures of IP-
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binding proteins will hopefully provide additional insights to allow general rules for 
governing IP binding and their impact in protein activity and function. 
 
Molecular mechanisms for IP regulation of biological activities 
The molecular means by which IPs modulate protein function are 
speculated to include (1) serving as an essential structural cofactor, (2) triggering 
allosteric or induced fit structural changes, or (3) by direct antagonistic substrate 
competition. 
Two recent reports suggest that IP6 functions as a required cofactor for 
proper protein folding. The human RNA-editing enzyme human adenosine 
deaminases acting on RNA (ADAR)2 and the F-box protein subunit of the 
ubiquitin–ligase complex SCF (Tir1) were both serendipitously cocrystallized with 
IP6 that remained tightly associated throughout rounds of protein purification 
(Macbeth et al. 2005; Tan et al. 2007). Heterologous expression of hADAR2 in 
budding yeast showed that the production of IP6 is essential for hADAR2 stability 
and activity (Macbeth et al. 2005). For Tir1, IP6 interacts with several structurally 
important elements of the tertiary structure (Tan et al. 2007); however, an 
essential role for IP6 in SCF–ubiquitin activity has not been directly demonstrated. 
The allosteric potential for IPs in protein function has been elegantly 
demonstrated by classical studies with the tetrameric IP3 receptor (Foskett et al. 
2007), wherein IP3 binding results in structural changes required for channel 
relaxation and endoplasmic Ca2+ release. It has also been shown that IP3 and IP7 
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function as antagonistic competitors of PIP binding by pleckstrin homology (PH) 
domain-containing proteins, in mammals and Dictyostelium, respectively (Hirose 
et al. 1999; Luo et al. 2003). This IP-PIP competition is not surprising given the 
obvious structural similarities between the IPs and the head groups of their lipid 
counterparts. Strikingly, others have shown that IP4 has a positive impact on the 
plasma membrane recruitment of several PH domain-containing proteins (Huang 
et al. 2007). The authors suggest that this reflects an induced fit model by which 
IP4 binding functions as a priming event to induce allosteric changes in PH 
domains and results in higher affinity-binding pockets for PIP3. Undoubtedly, 
physiological and structural data on the modulation of IP targets such as Ku70/80 
(Hanakahi and West 2002), and the Pho80–Pho85 CDK complex (Lee et al. 
2007) will reveal additional clues on IP-mediated protein regulation. 
 
Concluding remarks 
mRNA export is a dynamic process that ties many steps in pre-RNA 
synthesis in the nucleus with protein translation in the cytoplasm.  Understanding 
how this machinery operates is of great importance to human physiology and 
disease. Moreover, regulation of this machinery could efficiently be employed 
during cell signaling, growth, and adaptation; accelerating or inhibiting the export 
of specific messages as the cell demands. This work embarks upon the 
understanding of the conserved mechanism of mRNA export in the budding yeast 
Saccharomyces cerevisiae. It gives particular interest to the molecular 
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mechanisms by which the mRNA export factor Gle1 and the small molecule IP6 
regulate mRNA export. These studies conclude that Gle1 and IP6 regulate the 
DEAD-box protein Dbp5 at the NPC. Furthermore, the molecular determinants in 
Gle1 that are required for IP6-mediated Dbp5 activation in vivo and in vitro are 
identified. Local activation of Dbp5 by Gle1 and IP6 is thought to remodel the 
mRNP to facilitate its directional transport and release in the cytoplasm. This 
study expands our understanding of nuclear mRNA export, allows us to draw 
striking comparisons to the protein export machinery, and provides a platform for 
understanding cellular physiology and disease.  
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CHAPTER II 
 
IP6 AND Gle1 REGULATE THE DEAD-BOX PROTEIN Dbp5 DURING mRNA 
EXPORT. 
 
Introduction 
It is well established that the directionality of the import and export of 
nuclear proteins through the NPC is controlled by interactions between 
karyopherin transport factors and the GTPase Ran (Pemberton and Paschal 
2005). In contrast, the export of most cellular mRNAs requires a novel transport 
factor Mex67 (also known as TAP and NXF1); reviewed in (Rodriguez 2004). 
Mex67 does not require RanGTP for function, but does bind mRNPs and a 
Mex67–Mtr2 heterodimer interacts with Nups. Thus, Mex67 may act as a bridge 
between the mRNP and the NPC. The directionality of mRNA transport is 
elegantly linked to controlled changes in the protein composition of the mRNP 
complexes. One set of factors involved in cotranscriptional mRNP assembly and 
mRNA processing is not present in the cytoplasm, and its specific removal from 
the nuclear mRNP is considered a prerequisite for export (Moore 2005). Other 
mRNA binding proteins are removed during the export process and are 
subsequently recycled back into the nucleus for future export events. It is likely 
that members of the DEAD-box helicase family mediate these mRNP protein 
remodelling steps at different stages along the mRNA biosynthetic and export 
                                                
This chapter is adapted from “Inositol hexakisphosphate and Gle1 activate the DEAD-
box protein Dbp5 for nuclear mRNA export. Alcázar-Román AR, Tran EJ, Guo S, Wente 
SR. Nat. Cell. Biol. 2006 8(7): 711-6” 
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pathway (Rocak and Linder 2004). The DEAD-box protein Dbp5 (also known as 
Rat8) shuttles between the nucleus and cytoplasm (Hodge et al. 1999) and is 
recruited to mRNA during transcription by interaction with components of the 
transcription elongation factor TFIIH (Estruch and Cole 2003). Immuno-EM 
studies of the Balbiani ring-particle mRNP export have also shown that Dbp5 
stays associated with exporting transcripts from synthesis through to NPC 
translocation (Zhao et al. 2002). As Dbp5 interacts with Nup159 at the 
cytoplasmic fibrils of the NPC (Hodge et al. 1999; Schmitt et al. 1999; Weirich et 
al. 2004), it is predicted to act in mRNP remodelling specifically during NPC 
extrusion but the mechanism has not been defined. 
We have focused our efforts on analysing the role of NPC-associated Gle1 
(Kendirgi et al. 2003; Murphy and Wente 1996), a highly conserved, essential 
mRNA export factor. During our studies of Gle1 function, the enzymes 
responsible for the metabolic pathway that results in the production of soluble IP6 
by cleavage of membrane-anchored PI(4,5)P2 and sequential inositide 
phosphorylation (Odom et al. 2000; York et al. 1999) in budding yeast were 
identified. This pathway requires three enzymes: Plc1, Ipk2 and Ipk1. IP6 can 
also be converted to diphosphorylated inositols (such as diphosphoryl inositol 
1,3,4,5,6 pentakisphosphate; PP-IP5) by the enzyme Kcs1 (York et al. 2005). IPs 
are key regulatory molecules in many aspects of cell physiology and have been 
implicated in multiple protein–nucleic acid activities including chromatin 
remodelling, telomere length regulation and RNA editing (Macbeth et al. 2005; 
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Odom et al. 2000; Steger et al. 2003; York et al. 2005). The efficient export of 
mRNA specifically requires IP6 production by the IP5 2-kinase activity of Ipk1 
(Moore 2005). To define the mechanism by which IP6 production influences 
mRNA export, a systematic analysis of genetic interactions between the ipk1 null 
(∆) mutant and a panel of mutant genes encoding known Nups and 
nucleocytoplasmic transport factors was conducted (Miller 2004). A specific 
subset of mutants was identified, all of which are directly linked to Gle1 and Dbp5 
function and physically localized to a NPC substructure on the cytoplasmic fibrils. 
Here we identify a role for Gle1 and IP6 in the regulation of Dbp5 for mRNA 
export. 
 
Materials and methods 
Yeast media and manipulations 
Strains were grown in YPD (1% yeast extract, 2% peptone, 2% glucose) at 
23 ˚C unless otherwise noted. Synthetic media lacking appropriate amino acids 
was supplemented with 2% Glucose (SD). Media containing drugs for plasmid 
loss or drug resistance were supplemented as follows: 5-Fluoroorotic acid (5-
FOA; US Biological) was used at 1.0 mg/ml; G418 (US Biological) was used at 
200 µg/ml. Yeast cells were transformed using a lithium acetate method (Ito et al. 
1983). Genetic manipulations including yeast matings, dissections, and 
selections of desired yeast strains were done following standard techniques 
(Sherman et al. 1986). 
 42 
Yeast strains 
A list of strains used in this study in is Table 2. For strain SWY3547, the 
DHH1 gene was deleted by amplifying the kanamycin resistance gene using 
oligonucleotide primers that included sequence complementary to the flanking 
regions of DHH1. The PCR product was transformed into a wild-type diploid 
strain and kanamycin resistant colonies were sporulated and dissected. The 
dhh1∆ spores were confirmed by PCR-based analysis and rescue of temperature 
sensitivity by transformation with a DHH1 harboring plasmid (pSW3177). Double 
mutants used were generated by mating, sporulation and dissection of tetrads.  
 
Multicopy suppresor screen 
For the high copy suppression screen, the S. cerevisiae strain SWY2114 
(Miller 2004) was transformed with a genomic library in vector Yep13 (LEU2/2µ) 
(Nasmyth and Tatchell 1980). The ipk1∆ nup42∆ cells transformed with a yeast 
genomic library were plated on selective media, grown at 30 °C for 2 hours and 
then at 37 °C for seven days. Approximately 21,000 transformants were 
screened and the 48 resulting colonies were retested for growth and plasmid 
dependence. Plasmids from positive isolates were analysed by DNA sequencing. 
The strongest specific isolate contained a genomic fragment from chromosome 
IV spanning 7.2 kb that harbored DHH1 (pSW3175). Plasmids with individual 
open reading frames (ORFs) were generated and direct tests were conducted by 
transforming the ipk∆ nup42∆ strain and assaying for growth rescue. 
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 Plasmids 
 The plasmids used in this study are detailed in Table 2. The pIPK1/URA3 
(pSW1272) was constructed by PCR amplification of IPK1 from a library plasmid 
isolate using oligonucleotides complementary to pRS316 flanking sequences. 
The PCR product was cloned by gap-repair into the BamHI and SalI sites in a 
pRS316 vector containing ADE3 (pSW1157). The plasmid for bacterial 
expression of GST-Dbp5 (pSW1319) was constructed by PCR amplification of 
the DBP5 coding region from genomic yeast DNA with gene-specific 
oligonucleotide primers flanked by BamHI restriction sites. The resulting PCR 
product was subcloned into the BamHI site of pGEX-5X-3 (GE Healthcare). Full 
length wildtype DHH1 2µ (pSW3177) and PDE2 2µ (pSW3181) plasmids were 
constructed by PCR amplification from library plasmid isolate with 
oligonucleotides primers flanked with BamHI and Sal1 sites. The PCR product 
was subcloned into pRS425 (Christianson et al. 1992). The dhh1-E196Q 2µ 
plasmid (pSW3180) was constructed by oligonucleotide-directed in vitro 
mutagenesis of pSW3177. Expression of Dhh1-E196Q protein was confirmed by 
testing for rescue of temperature sensitive dhh1∆ (SWY3547) mutant cells at 30 
˚C.   
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 Protein expression and purification and IP6 
 Recombinant maltose binding protein (MBP)–Gle1 (pSW449) and GST–
Dbp5 (pSW1319) fusion proteins were expressed in Escherichia coli Rosetta 
(DE3) cells (EMD Biosciences). MBP–Gle1 was purified by affinity 
chromatography using amylose resin (New England Biolabs) according to 
manufacturers' instructions followed by SP FastFlow (Sigma) ion exchange 
chromatography. Purified MBP–Gle1 was dialysed against Buffer B (20 mM 
HEPES at pH 7.5, 150 mM NaCl, 20% w/v glycerol). GST–Dbp5 was affinity 
purified using glutathione resin (GE Healthcare). GST-tag removal was 
performed by cleavage with Factor Xa (New England Biolabs) during dialysis 
against Buffer B and untagged Dbp5 was isolated by a second passage over 
glutathione resin. IP6 was prepared by resuspending phytic (Sigma) acid in 50 
mM Hepes-HCL pH 7.5 and adjusting pH with 10 N NaOH to reach ~pH 7.5. pH 
was tested by placing a drop of solution on pH paper indicator (Litmus) and 
comparing to standards. IP6 solution was stored at 4 ˚C and prepared fresh every 
3 months. 
 
 ATPase assays and kinetic analysis 
 Dbp5 ATPase assays were conducted in a 10 µl total volume of Buffer A (16 
mM HEPES at pH 7.5, 120 mM NaCl, 3 mM MgCl2, 16% w/v glycerol, 1 mg ml-1 
BSA) supplemented with 1 U/µl SUPERasin (Ambion) and 1 mM DTT. 
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Recombinant proteins, IP6 (Sigma) and either a 25 mer poly(A)+ RNA 
oligonucleotide (Dharmacon, Layfayette, CO) or a 31 mer ssRNA (5'-
AUGUUGUUAUAGUAUCCCACCUACCCUGAUG-3') (kind gift  from Ron 
Emeson) were used as indicated, followed by addition of unlabelled ATP and 1 Ci 
-32P-ATP (3000 Ci mmol-1; PerkinElmer LAS, Wellesley, MA). The amounts of 
recombinant proteins used, and the incubation times, were varied to maintain 
substrate conversion within a linear range. Reactions were incubated for 10 min 
at 30 °C, unless otherwise noted, and stopped with 2µl 50 mM Tris at pH 7.4, 5 
mM EDTA, 1.5% SDS and 2 mg ml-1 proteinase K (Ambion). After 30 min at 37 
°C, sample fractions were spotted onto PEI-cellulose thin-layer chromatography 
sheets (Mallinckrodt Baker) and separation of ADP and ATP was achieved by 
incubation in 0.6 M potassium phosphate at pH 3.4. Radioactivity was detected 
using a Typhoon 9200 Imager and quantified using Image Quant v. 5.2 
(Molecular Dynamics, Inc.). Apparent kinetic parameters and EC-50 values were 
calculated using GraphPad Prism v.4 software. For EC-50 determination, data 
was fit using a dose-response curve with variable slope and setting top and 
bottom constraints at 100% and 0% activation, respectively. Dbp5 catalytic rates 
were obtained by considering the initial reaction rates and fitting the data to the 
Michaelis-Menten equation saturation plot. All kinetic and EC-50 measurements 
were calculated using a least square approximation for data fitting. 
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IP6 binding and stability assays 
 A modified polyethylene glycol (PEG)-precipitation assay was used to 
measure IP6 binding (Shears 1997). In brief, 30 µl binding reactions were 
conducted with 10 nM 3H-IP6 (21.4 Ci mmol-1; PerkinElmer LAS) in Buffer A and 
recombinant purified MBP–Gle1 and/or Dbp5. As indicated, reactions were 
performed in the presence of RNA (25 mer poly(A)+ RNA oligonucleotide; 
Dharmacon), ATP γ-S (Roche, Indianapolis, IN) and competing unlabelled 
inositides — IP6 (Sigma), IP5 (Matreya Inc., Pleasant Gap, PA) and IS6 (Sigma). 
Samples were incubated for 30 min at 30 °C and proteins were precipitated by 
adding 21 µl of 30% PEG 3350 (Sigma), followed by incubation on ice for 10 min. 
Precipitated proteins with bound 3H-IP6 were separated by centrifugation for 20 
min at 35,000g at 4 °C. The supernatant was aspirated and the pellets were 
solubilized with 300 µl 1% SDS. Radioactivity was measured by scintillation 
counting. To analyse IP6 stability during Dbp5 ATP hydrolysis, ATPase reactions 
were conducted (30 °C, 2 h, 500 nM Dbp5, 250 nM Gle1, 1 µM 3H-IP6 (3 nCi 
pmol-1)) and stopped by addition of 100 µl 0.5 M HCl. The 3H-IP6 levels were 
analysed by HPLC with a Partisphere strong-anion exchange column as 
previously described (York et al. 1999). 
 
 Analysis of steady-state GFP import cargoes and mRNA export 
defects 
 
 Wild-type and mutant strains containing reporters pGAD-GFP (cNLS-GFP) 
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or pSpo1276-130-GFP (Spo12-NLS-GFP) were grown to mid-log phase at 23°C 
or 30°C. Cultures were shifted to 36°C and processed as previously described 
(Strawn et al. 2004). The localization of poly(A)+ RNA was analyzed by growing 
strains in rich or synthetic medium at 23°C prior to shifting to 36°C for one hour. 
In situ hybridizations were performed using an digoxigenin-oligo (dT)30 probe as 
previously described (Iovine et al. 1995). Nuclei were visualized by 4',6-
diamidino-2-phenylindole (DAPI) staining. Cells were observed using a 
fluorescent microscope (model BX50; Olympus, Lake Success, NY) using an 
Uplan 100x/1.3 objective. Images were taken using a digital camera 
(Photometrics Cool Snap HQ) and process using MetaVue software (Universal 
Imaging) and Adobe Photoshop 7.0. 
 
Results 
 
IP6 and not IP7, is specifically required for proper mRNA export in vivo 
Genetic interactions between gle1 or dbp5 mutants and the kcs1∆ mutant, which 
lacks production of PP-IP5 from IP6, were examined (Figure 9 A). In contrast with 
the lethality of ipk1∆ gle1-2 and ipk1∆ dbp5-2 double mutants, kcs1∆ gle1-2 and 
kcs1∆ dbp5-2 mutants were viable. This supports our hypothesis that IP6 is 
directly required for mRNA export. In addition, there are no genetic interactions 
between the ipk1∆ mutant and mex67 mutants (Miller 2004), indicating that IP6 
and Mex67 execute two separate steps in the mRNA export pathway. A recent 
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report has linked IP6 production with the activity of the tRNA editing enzyme Tad1 
in budding yeast (Macbeth et al. 2005). We found there is no enhanced sickness 
interaction between tad1∆ and gle1-2 mutations suggesting that IP6 works 
independently in mRNA export and editing (data not shown).  
 
ipk1∆ nup42∆ mutant cells have temperature sensitive growth and 
mRNA export defects 
 
To gain further insight into the function of IP6 in mRNA export, the 
conditional ipk1∆ nup42∆ double mutant strain was characterized. At the non-
permissive growth temperature, mRNA export was defective (Figure 9 B). 
Interestingly, these defects were most prominent in rich media when compared to 
synthetic media (Figure 9 D). These results could suggest a potential regulation 
of mRNA export in different growth conditions. Such adaptations could have 
evolved to allow yeast colonies adjust growth and metabolic rates when found in 
less ideal environmental conditions in nature. In fact, bulk poly(A)+ mRNA is 
retained in the nucleus through an unknown mechanism during heat shock 
(Saavedra et al. 1997) and the mRNA export factor Dbp5 undergoes reversible 
changes in its localization during ethanol stress (Takemura et al. 2004), a 
condition in which cells also retain mRNA in the nucleus. We further 
characterized the ipk1∆ nup42∆ double mutant and found no perturbations in the 
steady-state localization of Gle1, Dbp5, or Mex67, or the nuclear import of protein 
cargoes by the nuclear transport factors, Kap95 and Kap121 (data not shown). 
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Overexpression of DBP5 rescues both growth and mRNA export defects of 
ipk1∆ nup42∆ cells 
 
As Nup42 provides the only reported NPC interaction site for yeast Gle1 
(Murphy and Wente 1996; Rollenhagen et al. 2004; Strahm et al. 1999) we 
predicted this strain was compromised in two specific ways and could be used to 
isolate mRNA export factors that required both IP6 production and efficient Gle1 
localization at the NPC cytoplasmic fibrils. A genetic screen was conducted in 
Saccharomyces cerevisiae for high-copy extragenic suppressors of the ipk1∆ 
nup42∆ double mutant temperature-sensitive lethality. A yeast 2µ genomic library 
was transformed into the ipk1∆ nup42∆ cells and colonies that grew at the non-
permissive temperature were selected. Two of the genes identified, PDE2 and 
SSD1, were tested independently for their ability to interact with other mRNA 
export factors genetically (Figure 10). Interestingly, overexpression of PDE2 also 
rescues the lethality of gle1-2 ipk1-5 mutant strains (Figure 10 A-B), but not 
dbp5-2 ipk1∆ cells (data not shown). PDE2 is one of two cyclic AMP (cAMP) 
phosphodiesterase enzymes that regulate cAMP levels in yeast (Mitsuzawa 
1993). Additionally, PDE2 has been found to have genetic interactions with SSD1 
(Matsuura and Anraku 1994), also isolated in this screen, and GLC7 (Uesono et 
al. 1997), a protein phosphatase with roles in many processes including mRNA 
export. SSD1 overexpression rescues the defect of mex67-5, ipk1∆ nup159-1, 
and ipk1∆ nup116∆ mutants (Figure 10 C-D). However, it did not rescue the 
defects of nup116∆, nup159-1, dbp5-2 or gle1-2 mutant strains (data not shown). 
SSD1 is a polymorphic locus with numerous genetic interactions (Kaeberlein et 
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al. 2004). Importantly, two alleles, designated SSD1-V and ssd1-d, have been 
identified for SSD1 and are found in laboratory and natural isolates. The ssd1-d 
allele is present in the parental strains used in this screen, and it is likely to 
produce a nonfunctional Ssd1 protein.  
 One novel high-copy plasmid was further characterized and found 
to harbour DHH1, the gene that was necessary and sufficient for rescue of 
lethality of ipk1∆ nup42∆ mutants (Figure 9 C). Dhh1 is a cytoplasmic DEAD-box 
helicase that stimulates mRNA decapping (Rocak and Linder 2004). To test 
whether the Dhh1 ATPase activity was required, a catalytically deficient dhh1-
E196Q mutant was generated. This mutant did not rescue the ipk1∆ nup42∆ 
temperature-sensitive growth (Figure 9 C). It has been reported that dhh1 
mutants enhance the lethality of dbp5 mutants, suggesting functional overlap 
between Dhh1 and Dbp5 (Tseng-Rogenski et al. 2003). In direct tests, it was 
found that DBP5 overexpression suppressed the ipk1∆ nup42∆ growth defect 
(Figure 9 C). Interestingly, DBP5 overexpression also rescued the mRNA export 
defects (Figure 9 B), whereas DHH1 did not (data not shown). Overexpression of 
DBP4 (an unrelated DEAD-box helicase) (Rocak and Linder 2004), GLE1 or 
GFD1 (a Gle1 and Dbp5 interacting protein) (Hodge et al. 1999; Strahm et al. 
1999) did not rescue the ipk1∆ nup42∆ lethality (Figure 9 B) and data not shown). 
The dhh1∆ ipk1∆ double mutant was viable (Figure 9 A), whereas the dbp5-2  
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ipk1∆ mutant is inviable at all growth temperatures (Miller 2004). This suggested 
that bypassing the mRNA export defect in the ipk1∆ nup42∆ mutant specifically 
required Dbp5. We concluded that the partial rescue of the ipk1∆ nup42∆ mutant 
by overexpressing DHH1 was indirect and due to either the partial functional 
overlap between Dbp5 and Dhh1 (Tseng-Rogenski et al. 2003), or due to altered 
flux in the global mRNA biosynthetic pathway and potential connections between 
mRNA export and turnover (Moore 2005). Based on these results and published 
genetic data tightly linking GLE1, IPK1 and DBP5 function (Hodge et al. 1999; 
Miller 2004; Strahm et al. 1999; York et al. 1999), we speculated that IP6 and 
Gle1 were directly required for Dbp5 activity. 
 
IP6 and Gle1 stimulate Dbp5 ATPase activity in vitro 
 To test this hypothesis, an in vitro system for assaying the RNA-
dependent ATPase activity of Dbp5 was established using bacterially expressed 
purified factors (Figure 11 A). ATPase reactions were determined to be dose and 
time dependent. It has been reported that purified recombinant Dbp5 has 
ATPase activity; however, in vitro unwinding of RNA was demonstrated only with 
Dbp5 in cell extracts, suggesting unidentified cellular cofactors are required for 
optimal function (Schmitt et al. 1999; Tseng et al. 1998). Recombinant Dbp5 (500 
nM) did have ATPase activity (Figure 11 B). Addition of only IP6 had no effect on 
the RNA-dependent Dbp5 ATPase activity level; however, Gle1 addition alone 
resulted in twofold activation of Dbp5 (Figure 11 B). Gle1 alone, or Gle1 plus IP6, 
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had no apparent ATPase activity (data not shown). Surprisingly, addition of both 
Gle1 (250 nM) and IP6 (100 nM) stimulated the Dbp5 ATPase activity nearly 
fivefold (Figure 11 B). The same effects were observed with either a 
heteropolymeric ssRNA (data not shown) or a poly(A)+ ssRNA. The half-maximal 
effective concentration (EC-50) for IP6 activation was 27.3 nM, with a 95% 
confidence interval from 20.3–36.7 nM at 500 nM Dbp5 and 250 nM Gle1 (Figure 
11 C). At higher IP6 concentrations the activation data did not fit a simple 
sigmoidal curve and this may reflect an additional level of complexity. In 
comparison, IP5 was significantly less effective at all concentrations tested (see 
Figure 12 and below). This correlated with prior observations that the elevated 
IP5 level in ipk1∆ cells did not rescue dbp5 or gle1 mutants, and indicated that 
specific stimulation of the ATPase activity of Dbp5 by IP6 is the physiologically 
relevant mechanism. Michaelis-Menten saturation kinetics were determined for 
Dbp5-driven ATP hydrolysis in the presence and absence of Gle1 and/or IP6 
(Figure 11 D). The apparent kcat was as follows: for Dbp5 alone it was 0.10 +/- 
0.01 sec-1; for Dbp5 + Gle1 it was 0.15 +/- 0.02 sec-1; and for Dbp5 + Gle1 + IP6 it 
was 0.29 +/- 0.02 sec-1. Thus, optimal activity required the presence of both Gle1 
and IP6. Under the same conditions plus 1 mM ATP, the RNA concentration for 
half-maximal activity was also markedly impacted (Figure 11 E). With Gle1 (250 
nM) and IP6 (100 nM), approximately 470 nM RNA was required for half-maximal 
activity. This was at least twentyfold lower in direct comparison with addition of  
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Gle1 alone, which required an RNA concentration in the 10–100 µM range. Gle1 
and IP6 work together to increase the catalytic efficiency of Dbp5 and decrease 
the RNA concentration threshold needed for Dbp5 activity. 
 
IP6 binds Gle1-Dbp5 
To analyse the mechanism of IP6 activation, IP6 binding was tested in an 
equilibrium-binding assay with purified recombinant Gle1 and Dbp5. Although 
Gle1 alone bound IP6, maximal binding required both Gle1 and Dbp5 (Figure 12 
A). Binding was specific, as increasing the concentration of unlabelled IP6 
effectively competed for radiolabelled 3H-IP6. In contrast, increasing the level of 
unlabelled IP5 or inositol hexakissulphate (IS6) did not decrease binding of IP6 
(Figure 12 B). To test the effect of Dbp5 substrates, IP6 binding was analysed in 
the presence of RNA and/or the non-hydrolysable analogue ATPγ-S. As shown in 
(Figure 12 C), no significant difference was noted suggesting IP6 binding to Gle1–
Dbp5 does not require Dbp5 catalytic activity. To test whether IP6 was altered 
during the assays, the Dbp5 ATPase reaction was carried out for 2 hours in the 
presence of 1 µM 3H-IP6 and Gle1. The inositide composition was analysed by 
HPLC and the IP6 level was not altered under these conditions (Figure 12 D). 
Thus, we conclude that IP6 is a stable binding partner that affects Gle1 and Dbp5. 
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Discussion: New model for mRNA export 
Taken together, we have defined a role for Gle1 and IP6 in activating Dbp5 
during mRNA export. We conclude that Gle1 and IP6 are previously 
uncharacterized Dbp5 cellular cofactors for stimulating its ATPase activity. We 
speculate that Gle1 and IP6 may also be required for Dbp5 RNA unwinding 
and/or the displacement of proteins from RNA–protein complexes. Our previous 
studies showed that Gle1 is recruited to the NPC independent of Dbp5 and 
Mex67 (Strawn et al. 2001) and it has also been shown that the Nup159–Dbp5 
interaction is key to Dbp5 activity in mRNA export (Hodge et al. 1999; Schmitt et 
al. 1999; Weirich et al. 2004). We speculate that mRNA export is dependent on 
the juxtaposition of Gle1 and Dbp5 at the cytoplasmic NPC fibrils during mRNP 
extrusion  (Figure 13). The respective binding sites on Nup42 and Nup159 would 
effectively serve as an interaction scaffold and facilitate this corecruitment. 
Indeed, under heat shock conditions in nup42∆ cells, NPC localization of both 
Gle1 and Dbp5 is diminished coincident with a block in mRNA export 
(Rollenhagen et al. 2004). 
These results provide evidence for spatial control of the mRNA export 
mechanism that may aid the establishment of directionality in mRNA export. It is 
predicted that DEAD-box proteins use the hydrolysis of ATP to either unwind 
RNA duplexes or dissociate RNA–protein complexes (Rocak and Linder 2004).  
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To date, two DEAD-box protein family members have been shown to 
remove or displace proteins from RNA (Fairman et al. 2004; Jankowsky et al. 
2001). It has also been proposed that Dbp5 acts to remodel the mRNP protein 
composition during export (Schmitt et al. 1999; Snay-Hodge et al. 1998; Tseng et 
al. 1998). Recent work showing Dbp5 is a necessary component for proper 
regulation of RNA-bound versus free Mex67 provides supporting evidence for 
this model (Lund and Guthrie 2005). Gle1 and IP6 activation of the Dbp5 ATPase 
may provide an input of energy to drive the release of critical mRNA binding 
proteins.   
 Yra1, Mex67 and Nab2 are candidates for release (Lund and Guthrie 
2005; Windgassen et al. 2004), whereas Npl3 is a candidate for being retained 
as a component of cytoplasmic mRNPs (Moore 2005; Windgassen et al. 2004). 
Such a bias between two different mRNP composition or conformational states 
may drive transport in a directional manner analogous to the classic Brownian 
ratchet. This work also reveals striking parallel control mechanisms for dictating 
transport directionality in both the Kap and mRNA export pathways — at the final 
export step the Kap pathways require a cytoplasmic GAP for stimulating Ran 
GTPase activity (Pemberton and Paschal 2005). Here, we show that Gle1 and 
IP6 can work as ATPase activating factors (AAFs) for stimulating Dbp5 at the 
NPC cytoplasmic face. 
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Interestingly, Dbp5, Gle1 and IP6 are not exclusively localized to the NPC. Dbp5 
shuttles between the nucleus and cytoplasm and interacts with components of 
the transcriptional elongation complex factor TFIIH (Estruch and Cole 2003) and 
Yra1, a nuclear mRNP protein involved in mRNA processing prior to export 
(Schmitt et al. 1999). There is evidence that human Gle1 also shuttles between 
the nucleus and the cytoplasm and interacts with both the vertebrate Nup42 
orthologue (hCG1) and a different Nup, human Nup155 (Kendirgi et al. 2003; 
Kendirgi et al. 2005; Rayala et al. 2004). Yeast Gle1 and Dbp5 both 
independently bind Gfd1, a non-essential cytoplasmic protein that associates 
with the shuttling mRNP protein Nab2 (Hodge et al. 1999; Strahm et al. 1999; 
Suntharalingam et al. 2004), and IP6 and soluble inositides are capable of 
diffusing throughout the cell (Miller 2004). Such localization at multiple cellular 
sites may result in Gle1–IP6 control of Dbp5 activation at other steps in the 
mRNP biosynthesis, processing, export, and/or turnover pathway. 
Total cellular IP6 levels are presumably high (in the micromolar range) 
(Shears 2001); however, the concentration of the free IP6 pool is unknown. We 
found that altering IP6 levels in the cell can impact Gle1 function and mRNA 
export. The complete lack of IP6 production, in addition to lowered IP6 levels in a 
catalytically compromised ipk1-5 mutant, are not sufficient for function of a gle1-2 
mutant (Ives et al. 2000; York et al. 1999). Conversely, elevated IP6 levels 
rescued a gle1-4 mutant (York et al. 1999). Although ipk1 cells are viable, growth 
is compromised at elevated temperatures (York et al. 1999). Thus, we speculate 
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that changes in IP6 levels may impact on mRNA export in vivo and allow highly 
efficient export under different growth conditions. Alternatively, the ability of IP6 to 
activate Dbp5 in a Gle1-dependent manner may reflect a general property of 
highly phosphorylated inositides to serve as enzyme cofactors. This is consistent 
with a recent report showing that IP6 is required for the activity and stability of 
adenosine deaminases that act on RNA (Macbeth et al. 2005). Dbp5 is a 
member of a large family of DEAD-box proteins (including approximately 30 in 
budding yeast) that have proposed functions in a range of RNA processing 
events, including ribosome biogenesis, mRNA splicing, mRNA export, mRNA 
translation and mRNA turnover (Rocak and Linder 2004). The mechanisms for 
regulating many of the DEAD-box proteins have not determined. Our findings 
suggest that these other cellular processes may follow this emerging paradigm 
and be controlled by soluble inositol polyphosphates. 
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Table 2: Yeast strains and plasmids used in Chapter II 
 
 
Strain 
Name 
Genotype 
Source 
SWY2114 MATa leu2 ura3 his3 ade2-1 trp1-1 ipk1::KANR nup42::HIS3 (Miller et al., 2004) 
SWY2649 MATa leu2 ura3 his3 trp1-1 can1-100 ipk1::KANR nup159-1 (Miller et al., 2004) 
SWY2246 MATa leu2 ade2-1 ura3 his3 trp1-1 can1-100 ipk1::KANR nup116::HIS3 (Miller et al., 2004) 
SWY2117 MATα ade2-1 ade3::hisG ura3-1 his3-11,15 trp1-1 leu2-3,112 lys2 ipk1::KANR This Study 
SWY3547 MATα ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 dhh1::KANR This Study 
SWY3608 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112  ipk1::KANR dhh1::KANR This Study 
LSY541 
MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 kcs1::HIS3   
(York et al 2005) 
SWY1181 MATα ade2-1 ura3-1 his3-11,15 leu2-3,112 lys2 gle1-2  This Study  
CSY550 MATa leu2∆1 trp1∆63 ura3-52 dbp5-2 (Snay-Hodge et al., 1998) 
SWY1793 MATa ade2-1 ade3 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100 gle1-2 ipk1-4 * (Miller et al., 2004) 
SWY1835 MATα ade2-1 ade3 ura3-1 his3-11,15 leu2-3,112 lys2 gle1-2 ipk1-2 * This Study 
SWY1837 MATα ade2-1 ade3 ura3-1 his3-11,15 leu2-3,112 lys2 gle1-2 ipk1-5 * This Study 
SWY3467 MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 gle1-2 kcs1::HIS3 This Study  
SWY2642 MATα ura3 his3 trp1 leu2 can1-100 dbp5-2 ipk1::KANR * This Study  
SWY3474 MATa ura3 his3 trp1 leu2 dbp5-2 kcs1::HIS3 This Study 
SWY2287 Mata ura3 trp1 leu2 mex67::HIS3 + MEX67/TRP1 This Study 
   
Plasmid 
Name 
Description Source 
pRS316 CEN/URA3 (Christianson et al., 1992) 
pRS315 CEN/LEU2 (Christianson et al., 1992) 
pSW1273 IPK1/ADE3/CEN/LEU2 (Miller et al., 2004) 
pSW1272 IPK1/ADE3/CEN/URA3 This Study 
pDBP4 DBP4/2µ/URA3 (Liang et al., 1997)  
pSW612 GLE1/CEN/URA3 (York et al., 1999) 
pCA5005 DBP5/CEN/URA3 (Teng et al., 1998) 
pSW449 Bacterial expression of MBP-Gle1  (Murphy and Wente 1996) 
pCS830 DBP5-myc/2µ/LEU2 (Snay-Hodge et al., 1998) 
pSW1319 Bacterial expression of GST-Dbp5  This Study 
pSW3174 SSD1/2µ/LEU2 This Study 
pSW3177 DHH1/2µ/LEU2 This Study 
pSW3181 PDE2/2µ/LEU2 This Study 
pSW3180 dhh1-E196Q/2µ/LEU2 This Study 
pSpo1276-
130-GFP 
SPO12 NLS fused to GFP under TPI promoter 2µ/LEU2 (Chaves and Blobel 2001) 
pGAD-
GFP 
SV40 NLS fused to three GFP under PHO4 promoter CEN/URA3 (Shulga et al., 1996) 
 
 * Requires pSW612 or pCA5005 for viability 
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CHAPTER III 
 
IDENTIFICATION OF MOLECULAR DETERMINANTS IN Gle1 FOR IP6-
MEDIATED Dbp5 ACTIVATION  
 
Introduction 
Directional transport of mRNA from the nucleus to the cytoplasm is a 
highly orchestrated process that bridges nuclear mRNA processing events to 
protein synthesis in the cytoplasm. Soluble mRNA export factors that mediate 
NPC interaction and translocation associate with the mRNA throughout the 
maturation process, serving a dual role of transport receptors and mRNA 
processing regulators (Hieronymus and Silver 2004; McKee and Silver 2007; 
Rodriguez 2004; Saguez et al. 2005). Properly capped, spliced and 
polyadenylated mRNAs combined with their associated RNA binding proteins 
constitute mature mRNPs that are targeted for export. Members of the conserved 
Mex67/Mtr2 heterodimer family (also known as TAP/p15 or NXF1/NXT1) are 
thought to be the major mRNA export receptors, directly bridging mRNA to FG-
domains within the aqueous NPC channel (Gruter et al. 1998; Kohler and Hurt 
2007; Segref et al. 1997).  
EM studies of the Balbiani ring mRNP suggest that NPC translocation 
involves mRNP remodeling events (Daneholt 2001a) presumably resulting in 
displacement of nuclear resident proteins from the mRNP (Pinol-Roma and 
Dreyfuss 1992). These steps are thought to be required for subsequent rounds of 
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export. Even though the general steps required for mRNA export are thought to 
be followed by most mRNAs, the protein signature present in mature mRNPs is 
not homogeneous. For instance, intron-containing pre-mRNAs are loaded with 
exon-exon junctions during splicing, a mark that is absent in intronless mRNAs 
(Le Hir et al. 2001). Additionally, specific mRNPs subsets have been found to 
have differential association of Mex67 and Yra1 (Hieronymus and Silver 2003). 
The physiological relevance of mRNP protein signatures is illustrated by 
transcript specific mRNA export defects in yra1-1 and mex67-5 temperature-
sensitive mutants (Hieronymus and Silver 2003) and the lack of a SSA4 (hsp70) 
mRNA export defect during the general mRNA export block imposed by the heat 
shock response (Saavedra et al. 1997). Similar protein signatures in mRNP 
populations may be used to coordinate considerable modifications to the gene 
expression profile at the level of mRNA export. Importantly, transcript specific 
regulation has been observed in the splicing machinery by inhibiting splicing of a 
subset of messages during different environmental conditions in yeast (Pleiss et 
al. 2007a, b).  
Dbp5, a member of the DEAD-box helicase family of RNA-dependent 
ATPases, is thought to mediate mRNP remodeling through the displacement of 
protein from mRNAs (Snay-Hodge et al. 1998; Tseng et al. 1998). Dbp5 is 
cotranscriptionally recruited to the mRNP (Estruch and Cole 2003; Zhao et al. 
2002) and its ATPase activity is thought to be activated at the NPC by the 
conserved mRNA export factor Gle1 (Alcazar-Roman et al. 2006; Weirich et al. 
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2006). Importantly, further ATPase stimulation is provided by the small molecule 
IP6, the fully phosphorylated member of the soluble IPs signaling pathway. Thus, 
Gle1 and IP6 function as Dbp5 ATPase activating factors, promoting Dbp5 ADP 
accumulation. Dbp5 binding to ADP has been shown to induce important 
intramolecular changes in the structure of Dbp5 (Tran 2007). In fact, these 
changes allow Dbp5 to trigger specific RNA:protein remodeling events. Thus, the 
nuclear export of mRNAs from the nucleus to the cytoplasm is mediated by the 
temporal and spatial coordination of biochemical interactions between mRNAs, 
mRNA export factors, and nucleoporins. Here we define the biochemical 
interaction between Gle1 and IP6, and their relation to Dbp5. Furthermore, we 
identify residues in Gle1 required for IP6 binding and potentiation of Dbp5 
stimulation in vitro and in vivo.  
 
Materials and methods 
 
Yeast media and manipulations 
Strains were grown in YPD (1% yeast extract, 2% peptone, 2% glucose) at 
23 ˚C unless otherwise noted. Synthetic media lacking appropriate amino acids 
was supplemented with 2% Glucose (SD). Media containing drugs for plasmid 
loss or drug resistance were supplemented as follows: 5-FOA (US Biological) 
was used at 1.0 mg/ml. Yeast cells were transformed using a lithium acetate 
method (Ito et al. 1983).  
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Yeast strains 
A list of strains used in this study in is Table 4. To generate strains 
expressing different alleles of GLE1, we utilized a gle1∆ strain (Murphy and 
Wente 1996) with a plasmid harboring GLE1/URA3. This strain was transformed 
with plasmids containing wildtype or mutant alleles of GLE1 and LEU2. Resulting 
colonies were selected in –LEU media and streaked in 5-FOA plates to select for 
colonies that had lost the GLE1/URA3 plasmid. Resulting strains were grown in 
YPD for all studies thereafter.  
 
Plasmids 
The plasmids used in this study are detailed in Table 4. GLE1/LEU2/CEN 
(pSW399) and pMAL-TEV-Gle1 (pSW3242) vectors were used in 
oligonucleotide-based site-directed in vitro mutagenesis to create yeast 
(pSW3343, pSW3344, and pSW3345) and bacterial (pSW3291, pSW3292, 
pSW3293, and pSW3295) plasmids to express mutant alleles of gle1.   
  
 Protein purification and IP6 
Recombinant, bacterially expressed, and untagged Dbp5 and Gle1 protein 
were purified as described previously (Tran 2007). After purification, proteins 
were dialyzed in Buffer B (20 mM Hepes-HCL pH 7.5, 150 mM NaCl, 20% w/v 
glycerol). IP6 was prepared by resuspending phytic (Sigma) acid in 50 mM 
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Hepes-HCL pH 7.5 and adjusting pH with 10 N NaOH to reach ~pH 7.5. pH was 
tested by placing a drop of solution on pH paper indicator (Litmus) and 
comparing to standards. IP6 solution was stored at 4 ˚C and prepared fresh every 
3 months. 
   
ATPase assays 
Dbp5 ATPase assays were conducted as previously described (Huang 
and Hackney 1994) with the stated modifications. The ATPase reaction was 
conducted in a total volume of 60 µl containing: 10 mM Hepes-HCL pH 7.5, 45 
mM NaCl, 3 mM MgCl2, 1 mM DTT, 3 mM PEP, 0.21 mM NADH, 0.333 U/µl 
SUPERasin (Ambion), and 0.777 units of pyruvate kinase-lactate dehydrogenase 
(Sigma). Varying amounts of protein, RNA (25 mer poly(A), and IP6 was used 
and reactions were started by addition of ATP/Mg2+. Measurements were taken 
every 20 seconds by detecting the OD340 using Synergy HT Multi-mode 
mircroplate reader (Biotek). Rate of OD340 signal decline was then utilize to 
measure steady state ATPase activity.  
 
IP6 binding assays 
A modified PEG-precipitation assay was used to measure IP6 binding 
(Shears 1997). In brief, 60 µl binding reactions were conducted with 10 nM 3H-IP6 
(21.4 Ci mmol-1; PerkinElmer LAS) in Buffer A (16 mM HEPES at pH 7.5, 120 
mM NaCl, 3 mM MgCl2, 16% w/v glycerol, 1 mg ml-1 BSA) supplemented with 1 
 69 
U/µl SUPERasin (Ambion, Austin, TX). Gle1, Dbp5, RNA (25 mer poly(A)), and/or 
nucleotides were added as indicated. Samples were mixed and incubated at 
room temperature for 10 min. Proteins were precipitated by adding 40 µl of 30% 
PEG 3350 (Sigma), followed by severe mixing and incubation at 4 ˚C for 10 min. 
Precipitated proteins with bound 3H-IP6 were separated by centrifugation for 25 
min at full speed at 4 °C in a Beckman benchtop centrifuge. The supernatant was 
aspirated and the pellets were solubilized with 300 µl 1% SDS overnight. 
Radioactivity was measured by scintillation counting. Equilibirum binding kinetics 
and dissociation constants were determined using GraphPad Prism v.4 software. 
 
Microscopic analysis of mRNA export defects, Gle1 localization, and 
immunoblots 
 
 The localization of poly(A)+ RNA was analyzed by growing strains in rich at 
23°C prior to shifting to 37°C for one hour. Cells were collected, fixed in 3.7% 
formaldehyde and 20% methanol, and washed before processing for indirect 
fluorescence in situ hybridizations (FISH). In situs were performed using an 
digoxigenin-oligo(dT)30 probe as previously described (York et al. 1999). Indirect 
immunofluorescence were preformed as previously described (Wente et al. 
1992). Cells were incubated at 4 ˚C overnight with Gle1 antibodies (1:100) 
prepared in guinea pig (Cocalico) and affinity-purified . Primary antibody was 
detected using FITC-conjugated anti-guinea pig IgG (1:1000) for 60 min at room 
temperature. Nuclei were visualized by DAPI staining. Cells were observed using 
a fluorescent microscope (model BX50; Olympus, Lake Success, NY) using an 
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Uplan 100x/1.3 objective. Images were taken using a digital camera 
(Photometrics Cool Snap HQ: Roper Scientific) and process using MetaVue 
software (Universal Imaging, West Chester, PA) and Adobe Photoshop 7.0. 
Analysis of Gle1 protein levels in selected strains was performed using 
immunobloting. Cells grown at 23 ˚C were shifted to higher temperatures for 1 hr 
as indicated, collected, washed and processed for crude cell lysis as previously 
described (Yaffe and Schatz 1984). Proteins were separated by electrophoresis 
in SDS polyacrylamide gels for immunoblot analysis with anti-Gle1 (1:1000) 
derived from guinea pig (Cocalico) and anti-Pgk1 (1:4000) (mAb22c5 M. Probes).  
 
Results 
 
Dbp5 binding to Gle1 enhances IP6 binding in vitro 
We and others have previously demonstrated that Gle1 is the 
physiological target of IP6 during mRNA export and that Dbp5 stimulates the 
physical association of these two factors (Alcazar-Roman et al. 2006; Weirich et 
al. 2006). In order to define the precise impact of Dbp5 on the Gle1:IP6 interaction 
we experimentally determined the dissociation constant (Kd) between full length 
Gle1 and IP6. Equilibrium binding assays showed that Gle1 and IP6 interact 
strongly with a Kd of 94 nM with a 95% confidence interval from 67 to 121 nM 
(Figure 14 A). The apparent association (Kon) and dissociation (Koff) rate were too 
fast for our assays to determine (data not shown). Next we measured the 
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impact of Dbp5 on the Gle1-IP6 interaction. Gle1 bound IP6 with a Kd of 49.72 nM 
with a 95% confidence interval from 39.0 to 60.44 nM in the presence of 1 mM 
Dbp5 (Figure 14 A and Table 3). This two-fold increase in binding affinity is 
independent and not impacted by RNA and/or ATP (Figure 14 B). We then tested 
the ability of Dbp5 to stimulate Gle1:IP6 binding in the presence of saturating 
levels of the non-hydrolysable ATP analog AMP-PNP or ADP (Figure 14 B), 
factors known to induce structural changes on Dbp5 (Tran 2007). Interestingly, 
both Dbp5:AMP-PNP and Dbp5:ADP, in the presence or absence of RNA, were 
able to stimulate Gle1:IP6 binding. We conclude that the structural changes in 
Dbp5 resulting from ADP and/or ATP binding do not interfere with its ability to 
interact with Gle1. Furthermore, both reported conformations of Dbp5 are able to 
stimulate Gle1:IP6 binding.  
 
Dbp5 and Gle1 interact in vitro 
To gain insights into the association of Gle1 and Dbp5 we investigated the 
kinetics of Gle1-IP6 binding stimulation by Dbp5. With a Gle1 concentration of 25 
nM and an IP6 concentration of 10 nM, the half-maximal concentration of Dbp5 
needed for Gle1-IP6 binding stimulation was of 69 nM (Figure 14 C) with a 95% 
confidence interval from 51 to 137 nM. This result suggests that Dbp5 binds Gle1 
with high affinity, and that the apparent Kd of 70 nM defines the binding 
interaction of Dbp5 for Gle1. This was a surprising result since we have been 
unable to detect a stable interaction between these two proteins in vitro. We 
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conclude that transient interactions between Gle1-IP6 and Gle1-Dbp5 are a result 
of very fast Kon and Koff values, a property that fits with the model of transient 
interactions required for rapid mRNA export.   
 
Identification of residues in Gle1 necessary for IP6 binding 
The solution of the crystal structures of the C-terminal domain of hADAR2 
(Macbeth et al. 2005) and the F-box protein subunit of the ubiquitin ligase 
complex SCF (Tir1) (Tan et al. 2007) revealed a molecule of IP6 embedded in 
their tertiary structure. To accomplish binding of the very negative IP6 molecule, 
both proteins contain a highly positively charged pocket decorated with several 
lysine (K) and arginine (R) residues. Of note, the residues are spread through 
several hundred residues of the primary sequence. In the case of hADAR2, the 
residues responsible for IP6 binding are highly conserved from yeast to humans. 
Since depletion of IP6 coincides with accumulation of mRNA in the nucleus in 
human cells overexpressing SopB (Feng et al. 2001) and Schizosaccharomyces 
pombe ipk1∆ cells exhibit a mRNA export defect (Sarmah unpublished results), 
we hypothesize that the residues coordinating IP6 binding are also conserved in 
many Gle1 homologues. Sequence alignments identified four conserved 
positively charged residues present within stretches of medium to high 
conservation in the C-terminal domain of Gle1 (Figure 15a). We selected those 
residues for targeted mutagenesis. We replaced codons for lysine or arginine 
residues with glutamine (Q)-encoding codons to conserve the polarity and  
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relative size of the side chains. Gle1 expressed harboring a Q at position 417 
(R417Q) resulted in insoluble protein (data not shown). However, Gle1-K377Q, 
Gle1-K377Q K378Q, and Gle1-K494Q were completely soluble and were purified 
to homogeneity (Figure 15 B). To evaluate the role of these amino acids in the 
binding of IP6 by Gle1, we performed 3H-IP6 equilibrium binding assays and 
(Figure 15 C). The binding of Gle1 for IP6 was unaffected in Gle1-K494Q. 
However, Gle1-K377Q and especially Gle1-K377Q K378Q had close to 10- fold 
reduction in Gle1-IP6 binding affinity, 724.1 nM and 8251 nM respectively. 
Addition of 1 mM Dbp5 stimulated IP6 binding of Gle1-K494Q to similar levels to 
that observed for Gle1-wt. However, Gle1-K377Q and Gle1-K377Q K378Q still 
had a drastic deficiency in IP6 binding (Figure 15 D and Table 3).  
 
Conserved Gle1 residues K377 and K378 facilitate IP6-mediated Dbp5 
stimulation in vitro 
 
We and others have previously shown that Gle1 is able to stimulate the 
ATPase activity of Dbp5 in an IP6-independent fashion and that IP6 greatly 
potentiates this stimulation (Alcazar-Roman et al. 2006; Weirich et al. 2006). In 
order to test the role of Gle1 residues K494, K377 and K378 in the IP6-dependent 
stimulation of Dbp5 ATPase activity, we performed ATPase assays with 
increasing concentrations of Gle1 (Figure 15 E). Interestingly, Gle1, Gle1 K377Q, 
Gle1 K377Q K378Q, and Gle1 K494Q exhibited similar Dbp5 ATPase activation 
in the absence of IP6. We further stimulated Dbp5 ATPase activity by adding 100 
nM IP6 to the samples containing the highest Gle1 concentration (800 nM). In 
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Table 3: Dissociation constants of Gle1 and IP6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Protein Kd 95% confidence 
Gle1 94.37 nM 67.25 to 121.5 nM 
Gle1 K377Q 724.1 nM 244.7 to 1203 nM 
Gle1 K377Q K378Q 8251 nM 0 to 16680 nM 
Gle1 K494Q 141.2 nM 65.3 to 217.1 nM 
Gle1 + 1mM Dbp5 49.72 nM 39 to 60.44 nM 
Gle1 K377Q + 1mM Dbp5 1375 nM 811.2 to 1940 nM 
Gle1 K377Q K378Q + 1mM Dbp5 3374 nM 1751 to 4994 nM 
Gle1 K494Q + 1mM Dbp5 55.51 nM 26.67 to 84.35 nM 
 77 
samples containing Gle1 and Gle1 K494Q, the addition of IP6 induced ATPase 
activity dramatically. However, little or no increase in ATPase activity was 
observed in samples containing Gle1-K377Q and Gle1-K377Q K378Q upon IP6 
addition. These results indicate that the K377Q and K378Q are necessary for the 
IP6 mediated stimulation of Dbp5 ATPase activity, and that it is possible to 
decouple IP6 binding from Dbp5 binding and stimulation. Taken together, these in 
vitro assays strongly argue that the conserved Gle1 K377 and K378 residues are 
required for coordinating IP6-binding and potentiating the Gle1 activation of Dbp5 
ATPase activity by IP6.   
 
Cells harboring Gle1 K377Q and Gle1 K377Q K378Q have mRNA 
export defects 
 
It has been demonstrated that cells harboring the ipk1∆ mutation are 
viable at all temperatures but exhibit a weak mRNA export defect at 37 ˚C (York 
et al. 1999). This phenotype is presumably due to lack of cellular IP6 to target 
Gle1 and stimulate the ATPase activity of Dbp5. Our biochemical analysis has 
now characterized Gle1 proteins with a strong defect in IP6 binding while 
maintaining proper Dbp5 stimulation. Based on the above studies we predict that 
yeast cells expressing Gle1-K377Q and Gle1-K377Q K378Q will have a mRNA 
export defect when grown at 37 ˚C similar to ipk1∆ cells. Additionally, cells 
expressing Gle1-wt and Gle1-K494Q should have a wildtype phenotype. We 
generated strains using a plasmid shuffle strategy in which the chromosomal 
copy of GLE1 had been deleted and containing plasmid harboring either wildtype 
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or mutant alleles of GLE1. In situ hybridization with an oligo (dT) probe detected 
nuclear mRNA accumulation in both Gle1-K377Q- and Gle1-K377Q K378Q-
expressing strains at 37 ˚C but not in the Gle1-wt or Gle1-K494Q-expressing 
strains (Figure 16). Importantly, similar to ipk1∆ strains, all strains showed normal 
mRNA export at 30 ˚C. Strikingly, gle1-K377Q K378Q also showed mRNA 
accumulation at 23 ˚C, a phenotype not detected in the ipk1∆ strain or in the 
other Gle1 point mutant strains. This defect suggests the presence of additional 
defects in the gle1-K377Q K378Q strain not detected in our biochemical assays. 
In order to rule out defects in expression, stability and localization of Gle1 point 
mutants, we utilized anti-Gle1 polyclonal antibodies. We demonstrated that all 
tested alleles of Gle1 were stable within one hour of the temperature shift (Figure 
17 A), which was the standard condition used for all assays in this study. 
Additionally, immunofluorescence microscopy using anti-Gle1 antibodies showed 
proper nuclear rim localization for all strains tested (Figure 18). Next we 
assessed the viability of strains expressing the different Gle1 alleles at different 
temperatures. The mRNA export detected in the strain expressing Gle1-K377Q 
K378Q nicely correlated with growth defects evident in doubling times (data not 
shown) and serial dilution assays (Figure 17 B), as this strain had both high and 
low temperature sensitivity. Taken together, these observations confirm our 
biochemical analysis and corroborate the role of Gle1 residues K377 and K378 in 
IP6-binding and potentiating of Gle1 stimulation of Dbp5 ATPase activity in vivo 
and in vitro. 
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Discussion: IP6 as a regulator of mRNA export 
Taken together, we have defined the biochemical relationship between IP6 
binding to Gle1 and stimulation of Dbp5. We conclude that the tight but transient 
association of Gle1 to IP6 is due to fast Kon and Koff rates that are mediated 
through conserved positively charged amino acids in the C-terminal domain of 
Gle1. Furthermore, we demonstrate that these amino acids are responsible for 
transducing the IP6-driven stimulation of Dbp5 ATPase activity in vitro and in vivo. 
Our previous studies have identified a pivotal role for the Gle1/IP6-driven ATPase 
stimulation of Dbp5 in displacement of Nab2 from RNA (Tran 2007). We 
speculate that IP6 potentiation of Dbp5 activity will be crucial for displacement of 
proteins in specific mRNPs.  
Conceptually, transient protein interactions are expected to occur during 
the rapid mRNA export process. Consistent with this model, we determine that 
even though Gle1-IP6 and Gle1-Dbp5 dissociation constants are in the low 
nanomolar range, they cannot be captured as a stable complex in vitro (data not 
shown). We speculate that the NPC, through Nup159 and Nup42, provides a 
scaffold for the interaction of these proteins in vivo, and that additional cellular 
factors may regulate and participate in this interaction. Gfd1 is a prime candidate 
for this role, as it has genetic and direct physical interactions to Gle1, Dbp5, and 
Nab2 (Hodge et al. 1999; Strahm et al. 1999; Suntharalingam et al. 2004). 
Interestingly, mass spectrometry analysis has identified Gfd1 and Nup159 as 
protein whose phosphorylation profile changes in response to mating pheromone 
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(Gruhler et al. 2005)), a signal that activates one of the five mitogen-activated 
protein kinase (MAP) kinase pathways in yeast (Buehrer and Errede 1997). 
Regulation of these and other factors may be essential for the export of mRNPs 
with specific remodeling requirements during signaling or special growth 
conditions.  
Selective regulation of mRNA export has been reported for heat shock 
mRNAs (Farny et al. 2008; Saavedra et al. 1997); intronless and intron-
containing transcripts; (Luo et al. 2001); and histone mRNAs (Erkmann et al. 
2005). In some cases the mRNA nucleotide sequence allows direct association 
with export factors (Erkmann et al. 2005); whereas in other cases it impacts the 
global protein composition of the mRNP. As a result, the precise protein 
signature of a mature mRNP varies from message to message. We speculate 
that Dbp5 could be effective at displacing proteins present in a given mRNP, 
whereas being inefficient at remodeling other mRNPs. We have previously 
demonstrated that Dbp5 cycles between an ATP- and an ADP-bound forms (Tran 
2007). We now show that IP6 and Gle1 are able to bind both Dbp5 
conformations. We propose that IP6 is able to associate with Dbp5-Gle1 
complexes during and after ATP hydrolysis and regulate the remodeling of 
specific mRNPs as they exit the nucleus. Direct control over the efficiency of 
remodeling for these mRNPs could be mediated by changes of local IP6 levels 
that impact Gle1’s ability to stimulate Dbp5.  
 Efficient mRNA export during cell signaling would aid in a rapid cellular 
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response. The phosphate-responsive signaling pathway (PHO) pathway is an 
attractive candidate to test for differential regulation of mRNA export by IP6. 
During phosphate starvation IP7 promotes the nuclear localization of the Pho4 
transcription factor (Lee et al. 2007) whereas IP4/IP5 regulate chromatin 
remodeling at Pho4 responsive promoters (Steger et al. 2003). Pho4 promotes 
the production of PHO5, PHO11, PHO12 and PHO84 mRNAs during the PHO 
signaling pathway (Carroll et al. 2001). I hypothesize that the export of these 
messages would be slower in a cell that does not produce IP6.  
 Pharmacological induction of the PHO pathway can be achieved by the 
utilization of a PHO85F82G allele and 4 -Amino-1-tert-butyl-3-(1’-naphthyl) pyrazolo 
[3,4-d] pyrimidine (1-Na-PP1) (Carroll et al. 2001). This pharmacological strategy 
bypasses the requirement of producing IP7, induces rapid nuclear localization of 
Pho4, and is sufficient for the production of PHO responsive mRNAs. mRNA 
export of PHO specific messages would be compared in ipk1∆ PHO85F82G and 
IPK1 PHO85F82G cells in the presence of 1-Na-PP1. Since chromosome 
remodeling of Pho4-responsive genes is not dramatically perturbed by the ipk1∆ 
mutation (Steger et al. 2003), PHO messages should be efficiently expressed in 
this strain. As a control, the export of PGK1, an abundant message in the cell, 
would need to be monitored. Additionally, the gle1-K377Q mutation would be 
added to the PHO85F82G strain to test the requirement of IP6 regulation through 
Gle1 in PHO mRNA export. Finally, the mex67-5 mutation would be added as a 
positive control of general mRNA export defects. Detection of PHO messages 
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would be conducted through FISH utilizing message-specific probes with 4 to 5 
fluorophores attached (Dong et al. 2007). Individual probes would be designed to 
recognize areas of high sequence homology of PHO5, PHO11, and PHO12 
mRNAs to increase FISH signal. As a precaution, the PHO3 gene, which is highly 
homologous to PHO5 and is not under the control of the PHO signaling pathway, 
would be chromosomally deleted from all strains to be used.  
 IP6 is an abundant molecule in the cell. However, the concentration of free 
IP6 at specific cellular locales is unknown. Genetic manipulations of GLE1 have 
now allowed us to uncouple IP6 signaling from mRNA export. Additionally, recent 
studies in our laboratory, focused on translation initiation and termination, 
suggest that Gle1 and IP6 do not always work together (Bolger T. et al., 
Submitted). Thus, IP6 may only associate with Gle1 to coordinate specific cellular 
functions.  
This study adds to the growing list of PIPs and IPs found to be regulators 
of gene expression. In addition the nuclear production of IP4/IP5 and IP7 that 
regulate PHO responsive genes, PI(4,5)P2 has been recently shown to regulate 
the expression of oxidative stress response genes by regulating the 
polyadenylation of their mRNAs (Mellman et al. 2008). Additionally, Plc1 has 
been connected to the regulation of high osmolarity glycerol response (HOG) 
pathway messages (Guha et al. 2007). Signal transduction pathways that utilize 
PIPs and IPs as secondary massagers are being uncovered as message specific 
gene expression modulators at the level of transcription, export, and translation. 
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These signaling mechanisms are poised to facilitate the dynamic expression 
profiles manifested in different cell types during metazoan development.  
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Table 4: Yeast strains and plasmids used in Chapter III 
 
 
Strain 
Name 
Genotype 
Source 
SWY1831 Mat @ gle1::HIS3 ade2 ADE3 ura3 his3 leu2 trp1 LYS2 can1 + pSW410 (Murphy and Wente 1996) 
pSW3826 Mat @ gle1::HIS3 ade2 ADE3 ura3 his3 leu2 trp1 LYS2 can1 + pSW399 This Study 
pSW3823 Mat @ gle1::HIS3 ade2 ADE3 ura3 his3 leu2 trp1 LYS2 can1 + pSW3343 This Study 
pSW3825 Mat @ gle1::HIS3 ade2 ADE3 ura3 his3 leu2 trp1 LYS2 can1 + pSW3345 This Study 
pSW3824 Mat @ gle1::HIS3 ade2 ADE3 ura3 his3 leu2 trp1 LYS2 can1 + pSW3344 This Study 
SWY2117 MATα ade2-1 ade3::hisG ura3-1 his3-11,15 trp1-1 leu2-3,112 lys2 ipk1::KANR (Alcazar-Roman et al., 
2006) 
   
Plasmid 
Name 
Description Source 
pSW410 GLE1/CEN/URA3 (Murphy and Wente 1996) 
pSW399 GLE1/CEN/LEU2 (Murphy and Wente 1996) 
pSW3343 gle1-K377Q/CEN/LEU2 This Study 
pSW3345 gle1-K377Q K378Q/CEN/LEU2 This Study 
pSW3344 gle1-K494Q/CEN/LEU2 This Study  
pSW3242 Bacterial expression of MBP-TEV-Gle1  (Tran et al., 2007)  
pSW3319 Bacterial expression of GST-Dbp5  This Study 
pSW3291 Bacterial expression of MBP-TEV-Gle1 K377Q  This Study 
pSW3293 Bacterial expression of MBP-TEV-Gle1 K377Q K378Q This Study 
pSW3292 Bacterial expression of MBP-TEV-Gle1 K494Q This Study 
pSW3295 Bacterial expression of MBP-TEV-Gle1 R417Q This Study 
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CHAPTER IV 
 
FUTURE DIRECTIONS 
 
Introduction 
mRNA export is vital for the fluent communication between the nucleus 
and the cytoplasm, a property required for rapid changes in gene expression 
profile (Rodriguez 2004; Saguez et al. 2005) (Gross et al. 2007; McKee and 
Silver 2007). The budding yeast Saccharomyces cerevisiae has been in the 
forefront of these studies due to its facile genetic manipulation and tractability. 
These techniques have allowed the field to identify numerous mRNA export 
factors and regulators. However, our understanding of mRNA export has 
undoubtedly reached a point at which biochemical dissection is required. In this 
aspect too, budding yeast proteins and complexes have been selected for 
purification and crystallization (Madrid and Weis 2006). The strength of combined 
biochemical and genetic approaches is manifested by the ability to test in vivo 
predictions derived from biochemical studies.  
The utilization of yeast as a model system for the study of mRNA export is 
at its prime. However, it is important to underline that metazoan cells have 
specialized, and in some cases, developed alternative strategies for the export of 
mRNAs. Studies like the genome-wide RNAi screen performed by Pam Silver 
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and colleagues to detect factors required for mRNA export in drosophila culture 
cells are crucial to expand our knowledge of this process in metazoans.   
We have now established a biochemical mechanism for Gle1, Dbp5 and 
IP6 in the later stages of mRNA export in yeast. The most urgent future direction 
is to test if hGle1B and hGle1A bind IP6 and activate hDbp5. Considering their 
primary sequence similarity, hGle1B and yGle1 should have similar biochemical 
properties. In fact, sequence alignment of both proteins suggests that hGle1 
would be able to bind IP6 (Figure 15 A). Once the biochemical properties of these 
human proteins have been determined, we could exploit the advantages of cell 
size provided by cell culture microscopy to decipher the roles of these proteins in 
vivo.  
 
Dynamics of Gle1 and Dbp5 regulation 
Both Gle1 and Dbp5 have a steady state NPC localization in vivo in yeast 
and human cells (Murphy and Wente 1996; Snay-Hodge et al. 1998; Tseng et al. 
1998; Watkins et al. 1998). However, it is now well established that Dbp5 and 
hGle1 shuttle between the nucleus and the cytoplasm. In the case of A. nidulans, 
Gle1 remains localized to the NPC during mitosis while FG-nups disperse 
throughout the cell (Osmani et al. 2006). It will be important to uncover what are 
the functional requirements and impact of Gle1 and Dbp5 localization and 
shuttling.  
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hGle1 shuttles between the nucleus and the cytoplasm by means of its 
shuttling domain (SD) (Kendirgi et al. 2003). The SD domain is present in both 
hGle1A and hGle1B, suggesting that both isomers are subject to 
nucleocytoplasmic exchange. However, a striking difference is observed when 
the localization of ectopically expressed hGle1A and hGle1B are compared. 
Unlike hGle1B, hGle1A does not contain an hCG1 binding site and does not have 
a strong steady state NPC localization (Kendirgi et al. 2005). Thus, hGle1B has a 
similar localization pattern to yGle1, and may have homologous roles in mRNA 
export. What is then the role of hGle1A? The high sequence similarity of yeast 
and human Dbp5 and Gle1 suggest that hGle1B and hGle1A are able to regulate 
hDbp5 activity. A possible role for hGle1A would be to regulate Dbp5 at different 
cellular locales. In fact, hGle1A is enriched in the cytoplasm. In light of the recent 
discovery of a role for yDbp5 in translation (Gross et al. 2007) an attractive 
possibility is that hGle1B regulates Dbp5 in mRNA export whereas hGle1A 
regulates Dbp5 in translation. Alternatively, hGle1B and hGle1A may play 
overlapping roles in mRNA export in different cell types. A careful examination of 
cell-type expression preferences for one isoform versus the other would be an 
important contribution to this dilemma. Even more provocative is the possibility 
that hGle1B and hGle1A have different subcellular localization patterns in 
different cell types. A simple experiment would be to conduct 
immunofluorescence and transient transfections of GFP-tagged hGle1 isoforms 
in a number of cell types, especially neurons.  
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It is unknown whether yGle1 shuttles. The SD contained in hGle1 is not 
conserved in the yeast homologue (Kendirgi et al. 2003). However, there is 
evidence to suggest nucleocytoplasmic shuttling is mediated by other molecular 
determinants. yGle1 has been shown to have an NPC steady-state localization in 
vivo by GFP-tagging strategies (Strawn et al. 2001) and in vitro by indirect 
immunofluorescence (Murphy and Wente 1996). However, higher resolution 
studies utilizing immuno-EM places yGle1 at both the cytoplasmic and 
nucleoplasmic sides of the NPC, albeit, with a strong prevalence towards the 
cytoplasmic face of the NPC (Miller 2004; Rout et al. 2000). Localization of yGle1 
at both faces of the NPC may represent transitory interactions during 
nucleocytoplasmic shuttling. Moreover, a small nine amino acid stretch of yGle1 
(aa 350-358) is sufficient to mediate nuclear export of an exogenous cargo 
(Murphy and Wente 1996).  
Gle1 shuttling in yeast and humans could be important to regulate Dbp5 or 
other DEAD-box helicases during mRNA processing, export and translation. 
Shuttling may also allow early Gle1 association with the mRNP during pre-mRNA 
processing. Gle1 shuttling raises another important question. How is Dbp5 
regulated at terminal steps of mRNA export if Gle1 shuttles? NPC components 
like Nup42/hCG1 and Nup159/CAN may facilitate local activation of Dbp5 by 
providing a scaffold platform that facilitates their interaction, or by removing 
inhibitory proteins allowing proper ATPase activation. Determination of the 
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precise dynamics of Gle1 localization during mRNA export is of crucial 
importance, and should follow the studies presented in this thesis.  
Gle1 localization dynamics might depend on gene expression. The model 
of mRNA export places Gle1 at the cytoplasmic face of the NPC awaiting the 
mature mRNP containing Dbp5 and Mex67 among other proteins. As the mRNP 
traverses the NPC, local activation of Dbp5 would be facilitated by its recruitment 
to Nup159, geographically situating Dbp5 next to Gle1 (see below). In this model, 
Gle1 localization is independent of mRNA transcription, export, and translation. 
To test this, genetic or pharmacological inhibition of transcription and translation 
would be used to observe Gle1-localization dynamics. Gle1 mislocalization 
during Pol II transcriptional inhibition should occur if Gle1 shuttles between the 
NPC and other sites of action. Furthermore, mislocalization might reveal 
additional sites of Gle1 activity. Similar studies could be performed utilizing 
pharmacological translational inhibitors. Additionally, energy depletion 
successfully utilized in the study of Mex67-GFP localization dynamics (Terry and 
Wente 2007) could be utilized to elucidate the energy requirements of Gle1 
localization. This question is of great importance as hGle1 is able to shuttle and 
its yeast homologue could play additional roles in the gene expression apparatus.  
A similar approach could be utilized to study Dbp5 localization dynamics. 
Are there populations of Dbp5 insensitive to energy depletion? Are there any 
changes in Dbp5 localization upon blocks to transcription or translation? In yeast, 
Dbp5-GFP localizes to the cytoplasm but mainly to the NPC (Snay-Hodge et al. 
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1998) whereas immunofluorescence utilizing Dbp5 antibodies detects Dbp5 at 
the NPC and in the cytoplasm at similar levels (Snay-Hodge et al. 1998; Tseng et 
al. 1998). This discrepancy could be attributed to background signal from Dbp5 
antibodies or defects in the tagged Dbp5-GFP protein. Immunofluorescence with 
Dbp5 antibodies on Dbp5-GFP expressing cells could solve this discrepancy. If 
cytoplasmic fluorescence remains, then it is likely due to background signal. On 
the contrary, if signal is higher at the NPC, then it is likely that GFP tagging of 
Dbp5 is deleterious to proper Dbp5 localization. Solving this dilemma would allow 
us to properly study Dbp5 localization dynamics. In fact, yDbp5 localization 
changes during different environmental conditions (Izawa et al. 2005a; Izawa et 
al. 2005b; Takemura et al. 2004), underlining the importance of this level of 
regulation. How are these changes achieved? What are the implications of these 
changes? Under ethanol stress, yDbp5 accumulates in the nucleus (Takemura et 
al. 2004). This localization is rapid and reversible. A cell under stressful 
conditions might require a cease of translational activity, thus restricting Dbp5 
localization to the nucleus. Conversely, cells recovering from stress might require 
high levels of cytoplasmic Dbp5 to cope with translational demands. Thus, 
studying Dbp5 localization dynamics could also provide a tool to better 
understand roles of Dbp5 apart from the NPC.  Additionally, utilization of a TAP-
tagged strategy under these conditions could enrich for Dbp5 binding partners in 
the nucleus or cytoplasm.  
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Due to the predominantly steady NPC localization, Dbp5 and Gle1 
colocalize in yeast and human cells. In vitro studies have now indicated that both 
proteins directly interact, albeit not forming a stable complex. To determine if 
Gle1 and Dbp5 interact at all sites of subcellular colocalization, I would utilize 
fluorescence resonance energy transfer (FRET). Proteins able to undergo FRET 
must be within 10 nm of each other (Hailey et al. 2002).  A FRET signal in the 
cytoplasm would strongly argue for a role of Dbp5 and Gle1 in cytoplasmic 
processes such as translation. 
Dbp5 has reported roles in transcription, export and translation (Estruch 
and Cole 2003; Gross et al. 2007; Snay-Hodge et al. 1998; Tseng et al. 1998). 
How does Dbp5 regulate all these processes? Recent biochemical evidence 
suggests that Dbp5 might work as a switch, shifting from ADP to ATP bound 
forms ((Tran 2007) and Introduction) (Figure 19 B). Furthermore, the relative 
affinity of Dbp5 for ADP is much higher than the one for ATP. Given that 
intracellular ATP levels range from 2-10 mM and that ADP levels are ~10 fold 
lower  (Delumeau et al. 2002; Lee et al. 2004b; Lu et al. 2002), a lower Kd for 
ADP would assure the stability of Dbp5-ADP during mRNA export. An attractive 
model centered on this cycle predicts that Dbp5-ATP plays roles in the nucleus 
while Gle1/IP6-driven ATP hydrolysis at the cytoplasmic side of the NPC would 
result in Dbp5-ADP playing roles in mRNA export and other cytoplasmic events. 
This model is strikingly similar to RanGTP hydrolysis cycles that regulate protein 
transport (Stewart 2007). If Dbp5 and Ran are regulated in a similar fashion, the 
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activator Gle1 represents the Dbp5 ATPase activating factor (AAF), stimulating 
Dbp5-ADP formation. How does Dbp5 cycle from an ADP- to an ATP-bound 
form? The simplest explanation would be that ATP could bind Dbp5 by displacing 
ADP. In support of this model ATPase assays in vitro suggest that Dbp5 can 
undergo many cycles of ATP hydrolysis in the absence of an exchange factor. 
This requires release of ADP followed by ATP binding. Importantly, early studies 
describing the GTPase activity of Ran indicates that, at least in vitro, Ran does 
not require an activator protein or an exchange factor for GTPase activity 
(Bischoff et al. 1994). So, similarly to Dbp5, Ran can cycle between NTP- and 
NDP-bound forms in vitro to support a low level of NTPase activity. However, in 
the cell RanGAP and RanGEF regulate Ran activity in a spatial manner. Is there 
a Dbp5 AEF to facilitate the exchange of ADP for ATP? If Dbp5 requires an AEF, 
this activity would likely be localized in the nucleus. Furthermore, Dbp5 AEF 
would bind Dbp5 only in a Dbp5-ADP form and not in a Dbp5-ATP form. Given 
these predictions, future efforts should concentrate in a biochemical strategy to 
identify Dbp5 binding proteins that associate with Dbp5 differentially in ADP 
versus ATP-bound forms. Recombinant GST-Dbp5-ADP, -AMP-PNP, or -APO 
could be used in pull down assays utilizing yeast extracts. Isolated proteins would 
be grouped in AMP-PNP dependent, ADP-dependent, or nucleotide impendent 
Dbp5 binding proteins. A potential Dbp5-AEF would be present in the ADP-
dependent group.  
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Visualization of Dbp5 structural changes in vivo is an extremely 
challenging task. However, modern technology is available to potentially allow 
tests of hypotheses in real time. Our model predicts that Dbp5 behaves like a 
molecular switch, changing from an ATP- to an ADP-bound conformation (Tran 
2007). These cycles have been shown to result in important structural changes in 
vitro. It is possible that Dbp5 remains in an ATP-bound form in the nucleus 
attached to mRNPs, and switches to an ADP-bound form at the NPC. Utilization 
of intramolecular FRET could indicate different structural conformations at distinct 
cellular locales . For instance, FRET might be facilitated by nuclear Dbp5-ATP 
and inhibited due to structural changes of Dbp5 when bound to ADP in the 
cytoplasm. GFP-hDbp5 is localized in the cytoplasm and at the NPC (Schmitt et 
al. 1999) and could provide an interesting model for these studies.  
Co-transcriptional recruitment of Dbp5 has been suggested by genetic and 
physical interactions of Dbp5 with the transcriptional machinery (Estruch and 
Cole 2003). Furthermore, Dbp5 only binds RNA in the presence of AMP-PNP 
(Weirich et al. 2006). A possibility is that Dbp5 is kept on an ATP-bound form as 
it associates with the pre-mRNP. However, an important question remains: How 
many Dbp5 molecules are present in a mature mRNP? If Dbp5 decorates mRNP 
molecules throughout their length, long messages should have a greater number 
of associated Dbp5 molecules as compared to short messages. To test this 
hypothesis mRNP reporters of different lengths could be designed with MS2 
binding sequences. After isolation of individual mRNPs, Dbp5 antibodies could 
 97 
be used to detect if Dbp5 isolation increases proportionally to mRNA length. UV 
cross-linking of yeast mutants with mRNA export defects and with disabled 
nuclear exosomes could be used to enrich for such messages in the nucleus. If in 
contrast, mRNPs contain a fixed number of Dbp5 molecules, the same amount of 
Dbp5 should be isolated with any message. These studies will be crucial in 
understanding the mechanism of mRNA export. If larger mRNPs require more 
Dbp5 for export, it might indicate that Dbp5 is a limiting factor in extruding the 
mRNP through the NPC, and that it acts at different points during this process. 
Additionally, if the same number of Dbp5 molecules is required for the export of 
short and long mRNPs, Dbp5 may operate at a define step or steps during 
mRNP NPC protrusion. Similar studies could be done for Mex67, Nab2, Pab1, 
and even Gle1. The composition and stoichiometry of an export competent 
mRNP is likely to play an important role in the export of diverse mRNP cargoes.  
The recent computational model of the NPC structure highlights the 
platform for local Dbp5 activation by Gle1 at the cytoplasmic side of the NPC 
(Alber et al. 2007a; Alber et al. 2007b) (Figure 1 A-C). Each of the eight pillars 
forming the NPC contains two columns that support adjacent Dbp5 and Gle1 
binding sites. An NPC engaged at maximal mRNA export efficiency could 
potentially support activation of eight Dbp5 molecules at the same time. In fact, 
computational analysis predicts that the stoichiometry of Gle1 at the NPC is 
identical to the one for Nup42 and Nup159 (Alber et al. 2007a). Whether each 
Dbp5 and Gle1 at the NPC is engaged in mRNA export or if eight mRNPs could 
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be exported at the same time is unknown and should be studied in the future. To 
understand this mechanism it will be critical to determine the residence time of an 
activated Dbp5 (Dbp5-ADP) at the NPC. 
 
Possible mechanisms of Dbp5 stimulation by Gle1 
In order to elucidate the precise role of Dbp5 in mRNA export, it is 
necessary to understand its biochemical properties. Biochemical characterization 
of Dbp5 has revealed binding to ATP/ADP, RNA, Nup159, Gle1, Gfd1, and Nab2 
(Cole and Scarcelli 2006). Furthermore, Dbp5 enzymatic activity is sensitive to 
Mg2+ levels, a conserved property in other DEAD-box helicases (Linder 2006; 
Schmitt et al. 1999; Tseng et al. 1998). How is Gle1 able to drastically stimulate 
Dbp5 ATPase activity? 
One possibility is that Gle1 may be able to stabilize a closed conformation 
of Dbp5, much like eIF4G regulates eIF4A (Oberer et al. 2005). Dbp5 in a closed 
conformation would then be able to hydrolyze ATP and bind RNA more efficiently 
(Figure 19 C). One prediction of this model is that Gle1 could interact with both 
Dbp5 N- and C-termini. Despite our efforts, detecting a stable interaction 
between Gle1 and Dbp5 has been elusive. In this model, repeated cycles of ATP-
hydrolysis would require constant assembly and disassembly of Dbp5-Gle1 
complexes, which might result in fast Koff and Kon rates. Nevertheless, we 
detected an interaction between Gle1 and Dbp5 in the low nanomolar range by 
means of Gle1-IP6 binding stimulation. I am currently using this method to  
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determine whether the N-, C- terminus or both regions of Dbp5 are sufficient for 
stimulation of IP6-binding by Gle1. RNA and nucleotide binding is thought to 
occur through interactions with residues in the cleft formed between the two 
globular domains of DEAD-box helicases (Linder 2006). It is likely that that 
recombinant bacterially purified Dbp5- C-terminal domain (CTD) and N-terminal 
domains (NTD) will not bind RNA or nucleotides independently or when 
combined. However, if Gle1 stimulates a closed conformation by simultaneously 
binding both the NTD and CTD of Dbp5 (or increase their association), partial 
recapitulation of RNA and nucleotide binding might be achieved. 
An additional possibility is that Gle1 binds to only one domain of Dbp5 
(Figure 19 C). This binding could result in allosteric changes in Dbp5 that account 
for increased sensitivity to RNA in ATPase assays. Since in this model Gle1 does 
not have to interact with two globular domains in Dbp5, a small region of Gle1 
could be sufficient for Dbp5 ATPase stimulation. Additionally, one of the globular 
domains of Dbp5 could be sufficient for full stimulation of Gle1-IP6 binding. 
In vitro, the CTD of Gle1 is sufficient for Dbp5 activation (Weirich et al. 
2006). In vivo, however, both the NTD and the CTD of Gle1 are essential 
(Watkins et al. 1998). What is the role of Gle1-NTD? Gle1-NTD can be divided in 
the extreme NTD and a predicted coiled-coil domain (Figure 19 A). The extreme 
NTD is not essential whereas the coiled-coil domain is (Watkins et al. 1998). To 
determine the function of the predicted coiled-coil domain, a battery of 
temperature sensitive mutants could be generated with amino acid substitutions 
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in the coiled-coil domain. These could be tested for mRNA export upon 
temperature shift. If the resulting Gle1 proteins are stable and localize to the 
NPC, accumulation of poly(A)+ RNA would suggest a role for that region of Gle1 
in mRNA export. Additional defects could be tested for mRNA processing or 
translation.  
The dynamics of Dbp5 activation cycles at the NPC suggests that Dbp5 
may simultaneously bind Nup159 and Gle1. Nup159 is able to stably interact with 
Dbp5 in the presence of AMP-PNP, ADP and in the absence of nucleotides 
(Weirich et al. 2004), which suggests that ATP hydrolysis can occur while Dbp5 
is bound to Nup159. At some point, Dbp5 must be released from Nup159 to 
achieve nucleocytoplasmic shuttling. How is temporal association of Nup159 
mediated? Candidate proteins necessary for this process are most likely 
contained within the mRNP (perhaps at the 3’ end of the message). Furthermore, 
Dbp5 binding partners like Gle1, Nab2 and Gfd1 might facilitate Nup159 removal 
by competitive binding. It is likely that mutations in DBP5 resulting in constitutive 
Dbp5-NPC localization will not associate with proteins that facilitate detachment 
from Nup159.   
Taken together, establishing an assay to calculate and determine Dbp5-
Gle1 interactions in the presence of Nup159, Nup42, and Gfd1 will allow direct 
testing of the importance of these proteins in Dbp5 ATP-ADP cycles and 
elucidate a potential mechanism for regulation Dbp5 localization dynamics. 
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Possible mechanisms of Dbp5 stimulation by IP6 
IP6 has been found to have many roles in cellular physiology (Alcazar-
Roman and Wente 2008; York 2006). IP6 might play regulatory roles in some 
processes whereas it might act as a cofactor in others. As a member of the IP 
signaling pathway, IP6 levels potentially change. In light of Ipk1 localization at the 
nuclear periphery, it is likely that IP6 levels can be spatially regulated. In mRNA 
export, IP6 drastically augments Dbp5 ATPase activity in a Gle1-dependent 
manner. During Dbp5 ATPase stimulation, IP6 interacts with the Gle1-CTD and is 
not hydrolyzed or modified in any way (Alcazar-Roman et al. 2006). How does 
IP6 stimulate Dbp5 activity? Elucidating the mode of IP6 regulation is tightly 
dependent on uncovering how Gle1 stimulates Dbp5 in the absence of IP6. 
Whether IP6 works as a regulatory molecule or as a cofactor, I propose three 
modes of action.  
IP6 might impact Gle1 through allosteric regulation. In this manner, IP6 
binding could increase the affinity of Gle1 for Dbp5, resulting in better activation 
in vitro and in vivo. Alternatively, if Gle1 stabilizes a closed conformation in Dbp5 
by behaving like a molecular clamp, IP6 binding might facilitate Gle1’s action in 
bringing the two globular domains of Dbp5 closer together. In other words, IP6 
binding could adjust the tightness of the clamp, and facilitate RNA/ATP binding 
and hydrolysis (Figure 19 D).  
Another possibility is that IP6 facilitates an interaction between Dbp5 and 
Gle1 by complementing a positively charged pocket formed when the two 
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proteins interact. By this mechanism, IP6 would behave as molecular glue (Figure 
19 C). This would account for the higher binding affinity for IP6 when Gle1 and 
Dbp5 are present together. Recent studies by O’Shea and co-workers have 
determined that IP7 induces structural changes in the Pho80/Pho85/Pho81 
complex (Lee et al. 2008). In short, upon IP7 binding, an additional segment of 
Pho81 is able to interact with the complex and inhibit Pho81 kinase activity. 
Similar to IP7, IP6 may induce a new Gle1 motif for interaction with Dbp5 further 
stimulating ATPase activity.  
Yet another possibility is that IP6 might participate in the ATPase reaction 
by contributing to the stabilization of an intermediate state of ATP/Dbp5 during 
the ATPase reaction. For instance, IP6 may help coordinate the Mg2+ needed for 
ATP hydrolysis. In fact, biochemical evidence suggests that IP6 associates with 
divalent cations in the cell, specifically Mg2+ (Veiga et al. 2006). Additionally, 
ipk1∆ mutants depend on proper Mg2+ homeostasis (Unpublished data). Although 
there is no evidence to support this model, it is appropriate to consider all 
possibilities.    
Recent biochemical and genetic studies in the Wente laboratory have 
demonstrated that Dbp5 displaces Nab2 from mRNA (Tran 2007). Furthermore, 
in vitro, Dbp5-ADP is sufficient for this activity. These observations suggest that 
Gle1 and IP6 are only required for the hydrolysis-driven change of Dbp5-ATP to 
Dbp5-ADP, and that ATP hydrolysis is not required for protein displacement. 
These observations are surprising and support the hypothesis of a role for Dbp5 
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as a ATP/ADP switch. Yet, many questions remain regarding the biochemical 
properties of Dbp5-ADP that allow such protein displacement. Undoubtedly, a 
combination of biochemical assays and structural biology data on these 
components engaged in ATP hydrolysis and protein-RNA remodeling will be 
required to reveal the secrets of mRNA export.  
It can then be speculated that Dbp5-ADP driven protein displacement at 
the cytoplasmic side of the NPC is crucial for mRNA export. For instance, Dbp5-
ADP could displace Mex67, Nab2 and other proteins to be recycled back in the 
nucleus for future rounds of export. Additionally, Dbp5 may allow the release of 
the mRNP from the NPC by releasing the interaction between NPC-bound 
proteins and the mRNA. Yet another possibility is that removal of specific mRNP 
proteins might expose binding sites for cytoplasmic factors to the mRNP 
important for mRNA localization and translation. It is likely that the entire 
collection of proteins targeted by Dbp5 include some factors that fit all the roles 
described above; nevertheless, a crucial molecular mechanism must exist to 
allow correct targeting of proteins to be removed by Dbp5. Direct binding to Dbp5 
might allow local remodeling in defined mRNP domains. Alternatively, Dbp5-ADP 
could be targeted to specific proteins by adaptors. These proteins would bridge 
the interaction by binding to both Dbp5-ADP and proteins to be displaced from 
the mRNA. Gfd1 fits both criteria by binding Dbp5 and Nab2 in vitro 
(Suntharalingam et al. 2004). Once the target is defined, Dbp5-ADP must drive 
dissociation of mRNA bound proteins. What is the mechanism of protein 
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displacement from RNA? Biochemical and biophysical data on the processive 
ATP-dependent dsRNA unwinding by DEAD-box helicases has defined that 
individual ATP-hydrolysis events are responsible for defined steps in the 
unwinding and translocation processes, and that these proteins work by locally 
melting of the dsRNA ahead of the opening fork (Cheng et al. 2007; Dumont et al. 
2006). Given that protein displacement by Dbp5 does not require ATP hydrolysis, 
it is possible that Dbp5-ADP bind the mRNP and undergoes conformational 
changes upon binding. These changes could force the local bending of the RNA 
and promote protein release. Alternatively, Dbp5-ADP could work by competing 
with mRNP proteins for RNA binding. Once the protein has been displaced, these 
could be re-imported into the nucleus. Additionally, the removal of these proteins 
would have a global effect on mRNP structure, which could be important for 
translation and localization.  
 
Dynamics of IP6 production, localization, and regulation 
Ipk1 is localized at the nuclear periphery in yeast cells (York et al. 1999). 
Thus, IP6 production is potentially situated at the site of Gle1-Dbp5 function. 
However, IP6 production specifically localized at the plasma membrane is able to 
regulate its target at the NPC and facilitate mRNA export (Miller 2004). What is 
then the evolutionary advantage for Ipk1 localization at the nuclear periphery? 
When thinking of IP6, it is imperative to consider the other nuclear functions 
reported for this molecule: mRNA editing, DNA repair, and chromatin remodeling
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(Hanakahi et al. 2000; Macbeth et al. 2005; Shen et al. 2003; Steger et al. 2003). 
In this light, localization of Ipk1 at the nuclear periphery might serve an important 
role in these or other unknown nuclear functions by placing production of IP6 at 
the gate of the NPC. A common pattern between the targeted production of IP6 
and its functions in the cell is also illustrated by studies of zebrafish Ipk1 (zfIpk1). 
In zebrafish, IP6 has a determinant role in the left-right asymmetric distribution of 
internal organs by controlling ciliary beating at the Kupffer’s vesicle (Sarmah et 
al. 2005; Sarmah et al. 2007).  Strikingly, zfIpk1 is enriched at the centrosomes 
and basal bodies of ciliated cells (Sarmah et al. 2007). Taken together, 
eukaryotic cells might establish and regulate the localization of IPs-producing 
enzymes to increase the local concentration of specific IPs and regulate cellular 
processes. Future studies aimed at understanding the full role and regulation of 
IPs will need to determine the molecular determinants for Ipk1 targeting to the 
nuclear periphery/basal body, and test if this localization is regulated. 
 Subcellular concentrations of IP6 and other IPs might be regulated. In fact, 
the localization of Ipk1 near NPCs suggests that IP6 levels might be higher at 
these sites. On the other hand, enzymes responsible for IP6 turnover could be 
localized at sites where IP6 is not required. A potential mechanism for regulating 
subcellular concentrations of IPs could also be achieved by active transport of 
IPs through membrane transporters. Eukaryotic cells have in place inositol 
transporters for extracellular intake of inositol (described above). Furthermore, in 
yeast, localization of these transporters is not restricted to the plasma membrane 
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(Huh et al. 2003). However, classic and recent studies have established that, at 
least for IP3 and IP7, a rapid burst of IP production is sufficient for signaling. A 
recent report suggests that Plc1 activation through G-protein-coupled receptors 
could potentially change cellular levels of most IPs (Otto et al. 2007). But how are 
these bursts achieved? There is no data describing the enzymatic activation or 
inhibition of IPs-kinases and phosphatases. We know, however, that Vip1 
produces IP7 upon phosphate starvation in yeast. Is Vip1 activated? Is the IP6 
pool made available to it? Yeast-two-hybrid screens utilizing IPs enzymes as 
baits, coupled to genetic studies in yeast should be utilized to identify these 
components. The localization and regulation of IPs kinases, and subcellular 
localization of their products are completely unknown and represents, in my 
opinion, the most fertile grounds for research in the IP field. 
 
IPs and regulation of gene expression 
Rapid and decisive changes in gene expression lie at the center of the 
cell’s innate ability to react to environmental changes or to complete cellular 
differentiation programs. In the nucleus, regulation of gene expression requires 
proper activation of chromatin-remodeling complexes, modulation of transcription 
factor activity, faithful mRNA processing, and efficient mRNA export. In 
metazoans, distinct and independent machineries exist for the regulation of 
nuclear PIPs from those in the cytoplasm (Cocco et al. 1987; Divecha et al. 1991; 
Martelli et al. 1991). In fact, dynamics of nuclear PIP2 serves in the regulation of 
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insulin growth factor 1 signaling (Cocco et al. 1998; Divecha et al. 1991), 
chromatin structure (Yu et al. 1998; Zhao et al. 1998), and indirectly in the pre-
mRNA processing machinery (Boronenkov et al. 1998; Osborne et al. 2001), thus 
impacting gene expression (Bunce et al. 2006; Gonzales and Anderson 2006; 
Irvine 2003). Interestingly, recent studies have revealed roles for specific soluble 
IPs in each in gene expression. Taken together, these studies suggest that IPs 
might coordinate cellular responses and orchestrate nuclear functions that impact 
the global gene expression mechanism. 
 
Transcriptional regulation 
The newly emerging paradigm of IPs as nuclear-signaling molecules is 
clearly evidenced by a series of recent discoveries in the PHO pathway which 
carefully coordinates cellular responses to phosphate starvation. In budding 
yeast, the cyclin-dependent kinase (CDK) Pho85 regulates a vast number of 
cellular functions (Carroll and O'Shea 2002). One of its associated cyclins, 
Pho80, directs Pho85 in its roles during PHO signaling. The CDK1 inhibitor 
Pho81 binds the CDK complex but only inhibits the CDK in response to Pi 
starvation (Figure 20). In the presence of high Pi levels, Pho80–Pho85 is active 
and phosphorylates the transcription factor Pho4. Phosphorylated Pho4 is 
exported to the cytoplasm and the Pi-responsive gene targets remain turned off. 
In response to Pi starvation, Pho81 inhibits Pho80–Pho85 phosphorylation of 
Pho4; thus, Pho4 remains nuclear and binds activation sequences in the PHO5 
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promoter (Fascher et al. 1990). Pho4 further recruits the chromatin-remodeling 
complexes INO80 and SWI/SNF (Steger et al. 2003), which help displace four 
positioned nucleosomes from the PHO5 promoter (Almer et al. 1986) facilitating 
PHO5 transcription. 
A recent report has biochemically identified IP7 as a signal for negative 
regulation of the Pho80–Pho85 CDK in a Pho81-dependent manner (Lee et al. 
2007). During Pi starvation, yeast cells increase IP7 levels sevenfold. This 
production of IP7 is required for in vivo Pho4-green fluorescent protein nuclear 
localization. This is presumably accomplished by IP7 binding to the Pho80–
Pho85–Pho81 complex. By this action, IP7 is sufficient to inactivate recombinant 
Pho80–Pho85 in a Pho81-dependent manner. Thus, the transcription factor Pho4 
is not phosphorylated by the CDK, not exported from the nucleus, and as such 
can activate PHO5 transcription (Komeili and O'Shea 1999). Importantly, IP7 from 
the Vip1-driven phosphorylation of IP6 and not the Kcs1-derived IP7 isoform is 
required for inactivation of the Pho80–Pho85 CDK. Vip1 may produce two forms 
of IP7 (Figure 8) (Mulugu et al. 2007). Future studies will determine whether 6PP-
IP5, its stereoisomeric cousin 4PP-IP5, or both participate in PHO signaling. To 
date, a number of studies have strengthened the role of IPs in transcriptional 
control (Auesukaree et al. 2005; El Alami et al. 2003; Odom et al. 2000; Romero 
et al. 2006), creating fertile ground for the biochemical dissection of these 
mechanisms. 
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Alteration of chromatin structure 
It is interesting to note that there are further independent connections 
between the production of IPs and function of the PHO-signaling pathway. In a 
genetic screen, mutant cells deficient in IP4 and IP5 production were found to 
have defects in nucleosome remodeling and PHO5 transcription (Steger et al. 
2003). Specifically, ipk2∆ mutants are deficient for recruitment of the INO80 and 
SWI/SNF chromatin-remodeling complexes to the PHO5 promoter. In an 
independent study, IP4 and IP5 were found to stimulate in vitro nucleosome 
remodeling by the SWI/SNF complex (Shen et al. 2003). IP6, on the other hand, 
inhibits the remodeling and ATPase activity of ISW2, INO80, and nucleosome-
remodeling factor complexes. The requirement for Plc1 and Ipk2 in the 
transcription of INO1 (Shen et al. 2003), a gene controlled by the SNF2, ISW2, 
and INO80 chromatin-remodeling complexes (Ebbert et al. 1999; Goldmark et al. 
2000; Peterson et al. 1991), suggests that the in vitro effects of IPs on chromatin 
remodeling are physiologically relevant. 
PHO is not the only cellular signaling pathway that utilizes IPs. Adaptation 
to osmotic changes in budding yeast utilizes the HOG MAP kinase pathway 
(Brewster et al. 1993; O'Rourke et al. 2002). Cells in hyperosmotic conditions 
activate a MAP kinase pathway that results in the phosphorylation and 
subsequent nuclear import of the Hog1 MAP kinase. Nuclear Hog1 regulates a 
number of transcriptional activators and repressors and results in a broad 
transcriptional response encompassing more than 500 genes (Hohmann 2002; 
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Posas et al. 2000; Rep et al. 2000). Concomitantly, osmotic changes trigger 
production of IPs (Ongusaha et al. 1998; Perera et al. 2004; Pesesse et al. 
2004). Indeed, plc1∆ mutant cells are osmosensitive (Flick and Thorner 1993) 
suggesting that production of IPs is essential for the proper response to osmotic 
stress. It is interesting to note that IP4 and IP5 have been recently implicated in 
the recruitment of the Snf1p-dependent Spt-Ada-Gcn5-acetyltransferase (SAGA) 
chromatin-remodeling complex to osmotically inducible promoters (Guha et al. 
2007). As opposed to wild-type cells, plc1∆ and ipk2∆ mutants do not recruit 
SAGA or the TATA-binding protein to HOG inducible promoters during 
hyperosmotic shock. Thus, plc1∆ and ipk2∆ cells are not viable under high 
osmolarity conditions. Taken together, both the PHO- and HOG-signaling 
pathways utilize IPs to modulate transcription of their target genes. 
The impact of IPs on multiple different steps in the gene expression 
pathway allows for a potentially integrated cellular response system (Figure 20). 
An attractive model could be centered on PHO signaling and IPs, based on the 
studies referenced above. Under conditions of Pi starvation and by yet unknown 
mechanisms, Plc1 and Vip1 localized in the nucleus are activated. Nuclear Ipk2, 
Ipk1, and Kcs1 rapidly convert IP3 into IP4 and other IPs, including IP7. IP7-
mediated inactivation of the Pho80–Pho85 kinase stimulates Pho4 nuclear 
retention. Nuclear Pho4 then binds accessible activation sequences in the PHO5 
promoter and recruit chromatin-remodeling complexes in an IP4/IP5-dependent 
manner. Transcription and maturation of PHO-responsive mRNPs could  
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potentially be coupled with IP6/Gle1 regulation of Dbp5 at the NPC, expediting 
directional release of key mRNPs in the cytoplasm. Thus, PHO-responsive genes 
have the potential to be regulated at multiple levels by different IP species. Many 
questions remain unsolved: Are all IP species produced during PHO signaling? Is 
IP7 produced from a pre-existing IP6 pool or from newly synthesized IP pools 
triggered by Plc1 signaling? How is the signal terminated? Such multitargeted 
cellular adjustments and positive feedback loops are often employed to ensure 
decisive and penetrant cellular responses. It is tantalizing to consider that the 
control of IPs allow coupling of multiple steps in the gene expression pathway for 
effective PHO signaling. 
 
Editing of messenger and tRNA 
The coordinated processing of transcribed RNA is directly linked to proper 
gene expression. ADARs or adenosine deaminases acting on tRNA (ADATs) are 
a family of enzymes that mediate the site-specific catalytic deamination of 
adenosine to produce inosine in RNA (Bass 2002). Deamination of targeted 
adenosines on mRNA happens cotranscriptionally within the nucleus. During 
mRNA splicing and translation, the inosine is recognized as guanosine resulting 
in differential splicing and codon usage (Bass 2002). It is interesting to note that 
the crystal structure of the hADAR2 C-terminal domain revealed a molecule of IP6 
buried within a basic pocket of the protein structure (Macbeth et al. 2005). This 
domain is necessary and sufficient for editing, and the enzyme activity requires 
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the presence of IP6. Similarly, Tad1, a member of the ADAT family in yeast, has a 
reduced capacity to edit tRNA in the absence of IP6. For both hADAR2 and yeast 
Tad1, the requirement for IP6 was surprising and suggests possible mechanisms 
for regulation of editing activity. 
Is IP6 directly regulating editing as a signaling molecule or serving as a 
cofactor for protein folding? Based on the structural analysis of the hADAR2 C-
terminal domain (Macbeth et al. 2005), the IP6 appears to play a structural 
cofactor role and is distinct from the catalytic site. Importantly, the established 
RNA targets of hADAR2 in human cells are found in the nervous system (Paul 
and Bass 1998) such as the 2C subtype of the serotonin receptor (Burns et al. 
1997) and the glutamate receptor (Lomeli et al. 1994). In fact, the level of editing 
on glutamate receptor mRNAs is developmentally regulated (Bernard and 
Khrestchatisky 1994). In parallel, Ipk1, the kinase that produces IP6, has dynamic 
expression patterns during embryogenesis and is present in adult neural tissue 
(Sarmah et al. 2005; Verbsky et al. 2005a) providing a platform for spatial and 
temporal regulation of ADAR2 activity during development. Furthermore, IP6-
coordinated mRNA editing could regulate gene expression by editing splice sites 
that would result in splice variants with greater stability and/or export potential. 
Alternatively, an altered splice site could produce an export-incompetent mRNA 
or a dysfunctional protein, as has been demonstrated by the self-regulation of 
hADAR2 activity (Rueter et al. 1999). Hyperedited RNAs are also shown to be 
retained in the nucleus (Zhang and Carmichael 2001), providing an additional 
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regulatory function for hADAR2/IP6 in gene expression. Future studies of the full-
length hADAR2 should provide a more complete story of the physiological role for 
IP6 function in RNA editing. 
 
 
Other nuclear roles for IPs 
 
In addition to gene expression, several other nuclear processes have been 
linked to the repertoire of IP-regulated mechanisms. Genetic, biochemical, and 
cell biological studies have shown that IPs regulate DNA repair, telomere 
homeostasis, and kinase-free phosphorylation of proteins within the nucleus. 
 
 
DNA repair 
Eukaryotic cells use two distinct mechanisms for repairing double-
stranded DNA breaks, homologous recombination (HR) and nonhomologous 
end-joining (NHEJ) (van Attikum and Gasser 2005; Zhou and Elledge 2000). The 
first evidence for the role of IPs in DNA repair came from a genetic screen in 
which a kcs1 mutant was found to be defective for DNA hyperrecombination 
characteristic in a protein kinase C1 (pkc1) mutant (Huang and Symington 1995). 
As the IP enzymatic properties of Kcs1 were uncovered, it was found that the 
abnormal HR of pkc1 mutants was linked to IP7 and IP8 production (Luo et al. 
2002). Independent support for the role of IPs in DNA repair was demonstrated in 
biochemical studies of the mammalian NHEJ mechanism. Using in vitro assays, 
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IP6 was identified as a potent stimulator of NHEJ (Hanakahi et al. 2000). The 
DNA-dependent protein kinase (DNA-PK) complex is recruited to double-
stranded DNA breaks where it plays a crucial role in NHEJ. IP6 binds the Ku70/80 
subunit of the DNA-PK complex (Hanakahi and West 2002; Ma and Lieber 2002) 
and presumably results in allosteric changes that impact kinase activity through 
increased stability or DNA binding of the holoenzyme (Hanakahi and West 2002). 
However, the mechanism for how IPs impact DNA repair remains elusive, and 
additional work is required to demonstrate the physiological impact. Although 
Ku70 protein dynamics are possibly altered in cells treated with calmodulin 
antagonists that reduce levels of all cellular IPs (Byrum et al. 2004), this effect 
could be indirect because of multiple other perturbations associated with 
disrupted Ca2+ homeostasis. It is interesting to note that ATP-dependent 
chromatin-remodeling complexes have roles in DNA repair (Downs et al. 2004; 
Morrison et al. 2004; van Attikum et al. 2004), and three components of the 
INO80 complex (Ino80, Arp5, and Arp8) are recruited to sites of double-strand 
breaks. Given the proposed roles for IP4/IP5 in INO80 chromatin remodeling, it is 
also intriguing to consider that IPs could regulate DNA repair through multiple 
mechanisms. 
 
Telomere length 
Two studies have provided in vivo evidence in budding yeast for the role of 
IPPs in maintenance of telomere length (Saiardi et al. 2005; York et al. 2005). As 
 117 
described in Fig. 2, Kcs1 utilizes IP5 or IP6 and phosphorylates a pre-existing 
phosphate in the 5-position to generate PP-IP4 and PP-IP5 (Saiardi et al. 1999), 
respectively. In kcs1 mutant cells, the telomeres are longer. Genetic studies 
suggest that PP-IP4 and not PP-IP5 impact telomere length (Saiardi et al. 2005; 
York et al. 2005). This indicates that an undefined target of PP-IP4 is able to 
distinguish the phosphorylation state of the axial 2-phosphate on the inositol ring. 
However, the telomere defects cannot be entirely attributed to lack of PP-IP4 
production. Expression of one of the three human inositol diphosphoryl synthases 
(hIP6K1) completely restores PP-IP4 production but fails to fully rescue telomere 
length defects (York et al. 2005). Nonenzymatic roles of Kcs1 and/or controlled 
timing and localization of PP-IP4 production might also be necessary for proper 
regulation of telomere length. Finally, Tel1, a protein kinase required for proper 
telomere maintenance, is indispensable for Kcs1 telomere regulation and thus 
seems to have roles downstream of Kcs1 (Saiardi et al. 2005; York et al. 2005). It 
is possible that PP-IP4 binds and regulates Tel1. Moreover, because both DNA-
PK and Tel1 are members of the phosphatidyl inositol 3-kinase-related kinase 
family and have roles in DNA damage response (Durocher and Jackson 2001; 
Pennaneach and Kolodner 2004; Zhou and Elledge 2000), Tel1 might be 
regulated by IPs in a manner similar to DNA-PK in the DNA repair mechanism. 
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Direct phosphorylation of nuclear proteins 
One of the most surprising functions attributed to IPs is the nonenzymatic 
phosphorylation of proteins by Kcs1-derived IP7 (5PP-IP5) (Saiardi et al. 2004). 
Using in vitro assay conditions, Kcs1-derived IP7 directly phosphorylates Nsr1, 
Srp40, and Ygr130c in the absence of a protein kinase. Nsr1 and Srp40 are both 
found in the nucleolus and are involved in ribosome biogenesis (Meier 1996; 
Stage-Zimmermann et al. 2000), suggesting that IP7 may have roles in ribosome 
maturation, processing, and/or transport. However, this has not been 
demonstrated. Although kcs1 mutant cells have reduced levels of Nsr1 
phosphorylation (Saiardi et al. 2004), nearly 40% of Nsr1 phosphorylation 
remains. Whether this non-Kcs1-linked Nsr1 phosphorylation represents protein 
kinase-driven or Vip1-derived IP7 (4/6PP-IP5) phosphorylation remains unknown. 
Overall, many questions remain regarding the mechanism, specificity, and 
requirements of the chemical reaction of phosphate transfer by IP7. 
 
Concluding remarks 
The abundance of IP species and their emerging roles in diverse aspects 
of nuclear cellular physiology suggests that cells utilize myo-inositol as an 
immensely versatile backbone for the production of second messengers. As 
described, these insights have come from a series of unrelated genetic and 
biochemical studies of fundamental nuclear processes (mRNA export, chromatin 
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remodeling, transcriptional activation, DNA repair, and RNA editing) that 
serendipitously discovered roles for IPs in their respective mechanisms. Taken 
together, this represents a fascinating new paradigm that places IPs as linchpins 
for coordinating multiple steps of the gene expression pathway from upstream 
signaling to mRNA export. 
The budding yeast model system has been especially fruitful in terms of 
revealing these nuclear functions because of a potential specialization and 
limited diversification of its IP signaling roles. In contrast to metazoan cells, S. 
cerevisiae has no reported IP3 receptor that modulates Ca2+ release, nor is there 
DAG regulation of protein kinase C (York 2006). However, it is well documented 
that IP3 serves as the precursor for the formation of the highly phosphorylated IPs 
(York et al. 1999). S. cerevisiae might possess only the nuclear highly 
phosphorylated IP functions as the rudimentary pathway required in all 
eukaryotes. Multicellular metazoan organisms and more recently evolved 
eukaryotes would have not only the nuclear functions for the highly 
phosphorylated IPs (e.g., IP5, IP6, IPPs) but also cytoplasmic roles for them. For 
example, recent studies have documented roles for Vip1 production of IP7 in 
cytokinesis of S. pombe (Mulugu et al. 2007). In addition, Ipk1 production of IP6 is 
required for ciliary beating in left–right asymmetry establishment in vertebrates 
(Sarmah et al. 2005; Sarmah et al. 2007), and enzymatic production of IPs is 
essential for in mouse early embryonic development (Frederick et al. 2005; 
Verbsky et al. 2005a). Thus, in both the nucleus and the cytoplasm, the spatial 
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and temporal activation of inositol-signaling pathways modulates protein 
machines and enables eukaryotic cells to sense changes in their environment. 
Unraveling the complexity of IP fluxes and potential coupling between the nuclear 
and cytoplasmic IP functions will be frontiers for future investigations. 
 To conclude, the studies presented here have focused on mRNA export 
regulation by IP6, Gle1, and Dbp5. In short, Gle1 directs mRNA export by 
spatially activating the ATPase activity of the DEAD-box protein Dbp5 at the 
NPC. Importantly, these studies have also demonstrated that IP6, a member of 
the IP-signaling pathway, can potentiate the Gle1-driven Dbp5 ATPase 
stimulation in vitro and impact Gle1 activity in vivo. Localized activation of 
ATPase activity at the cyoplasmic face of the NPC could account for the 
directionality of the mRNA export process. As a result, cytoplasmic NTPase 
activation seems to be a conserved mechanism governing nuclear export of 
proteins and mRNA. Additionally, the studies presented here enrich our 
understanding of how DEAD-box helicases could be regulated in a 
spatiotemporal manner. Finally, our studies contribute to the grater appreciation 
of IP control of gene expression. As a result of these studies, the field now seeks 
to understand the molecular mechanism by which Gle1 activates Dbp5, the 
mechanism by which Dbp5 is able to remodel a mRNP, and the regulation of 
transcript specific mRNA export. Significantly, these findings will bee important 
for the elucidation of abnormal functions of these players in viral pathogenesis 
and genetic disorders. In fact, a recent study has unveiled that 1% of the 
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population of Finland are heterogeneous for a specific mutation in hGLE1 
(Nousiainen et al. 2008). Homozygous embryos with hGLE1 lesions develop but 
die during gestation due to lethal congenital contracture syndrome 1 (LCCS1) 
and lethal arthrogryposis with anterior horn cell disease (LAAHD). Postmortem 
analyses reveals severe neurological defects. Importantly, similar conditions 
known as LCCS2 and LCCS3 are due to genetic lesions of IP signaling 
components (Narkis et al. 2007a; Narkis et al. 2007b). The study presented in 
this thesis describes a biochemical mechanism that strongly argues that hGle1 
and IP6 might play a common role in the regulation of a neuronal DEAD-box 
helicase, providing a potential platform for the studies of defective biochemical 
mechanism in these human diseases. 
 
 
 122 
Appendix 
 
A. RESPONSE TO HIGH OSMOLARITY IMPACTS mRNA EXPORT AND 
GROWTH OF mRNA EXPORT MUTANTS 
 
A number of reports have established that yeast cells under stress 
respond by altering its mRNA export capacity and blocking the export of general 
mRNAs (Saavedra et al. 1997; Carroll et al. 2001; O'Rourke et al. 2002). In 
yeast, the HOG pathway controls a cellular response to high osmolarity by 
activating a MAP-kinase pathway terminating in the phosphorylation and 
subsequent nuclear import of the Hog1 MAP-kinase. Nuclear Hog1 regulates a 
number of transcription factors and promotes transcription of HOG responsive 
genes. 
Since osmotic changes result in accumulation of IP6, and PLC1 is required 
for coping with high osmotic stress, we tested if high osmolarity would have an 
impact on mRNA export of wild type and cells carrying mutations in genes 
encoding mRNA export factors. Cells grown in high concentration of sorbitol, 
NaCl, MgCl2 or CaCl2 activate the HOG pathway. We have tested the impact in 
growth and mRNA export efficiency of mRNA export mutants in high osmolarity.  
We found that high osmolarity rescues the growth defect of strains lacking 
both IP6 production and containing mutations in NUP159, NUP42, NUP116, or 
GLE2. Further tests revealed that high osmolarity rescues both the growth and 
mRNA export defects of nup159-1, gle1-4, and mex67-5. Of note, the growth 
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defect suppression is remarkable using 300mM CaCl2 media at 37˚C for mex67-5 
and nup159-1.  Additionally, high osmolarity partially rescues the growth defect of 
nup116∆, dpb5-2 and glc7-5. Thus, suppression mRNA export defects overlap 
with suppression of growth defects at high temperatures. Additionally, these 
effects do not require IP6 production and affect different steps of the mRNA 
export process such as targeting by Mex67, and release by Dbp5.    
What is the physiological mechanism for this suppression of mRNA export 
defects? It is unknown whether or not Hog1 is required for this effect. We could 
utilize a hog1∆ mex67-5 mutant and test for the mRNA export defects at 37˚C in 
high osmolarity. It is possible that the activation of the HOG pathway alters the 
path of mRNA export through the NPC by modification of the mRNPs. An 
alternative hypothesis is that the NPC itself is a target of HOG regulation. It would 
be beneficial to study the defects of import and export in xpo1-1 mutants under 
high osmotic stress. If high osmolarity rescues the defects of xpo1-1 mutants, a 
general study of NPC permeability and composition should follow. Regulation of 
transport may allow rapid gene expression changes to cope with stress in harsh 
environmental conditions to which yeast cells are exposed in their natural habitat.  
 
 
 124 
B. 
 125 
 126 
 127 
 128 
 129 
Analysis, cloning, and expression of Gle1 proteins from fungal 
species. 
 
 
Gle1 is a conserved protein in Eukarya with a defined essential role in mRNA 
export. Studies in Saccharomyces cerevisiae have revealed a C-terminal domain that 
binds IP6 and stimulates Dbp5 ATPase activity. A sequence alignment with other fungal 
and metazoan species reveals areas of high homology within the C-terminal domain. The 
N-terminal domain, however, lacks areas of high homology and is challenging to analyze 
with bioinformatics. Figure B3 presents an alignment of Gle1 from different species. 
Interestingly, a marked difference is evident between higher eukaryotes and fungal 
species at many motifs in the C-terminus.  
Analysis of the C-terminus domain from all species identifies many conserved 
motifs. I described them here using the Saccharomyces cerevisiae numbering.  
E-A-P motif   sc326-365 
The E-A-P motif is the area of most homology in Gle1. It is called E-A-P due to 
the conserved E, A, and P residues in that region. In Gle1 sequences from Group 1 and 
Group 3 (see below) two proline residues form a boundary of this domain. 
DILA-KKCP motif  sc369-386 
The DILA-KKCP motif is the second area of high homology in Gle1. It contains 
amino acids important for IP6 binding.   
E-R-AAII motif  sc329-409 and 413-429 
This motif contains to sub-motifs with good homology, specially following the 
glutamic acid at position 392. The arginine at position 417 seems to be required for the 
solubility of Gle1 (see above).  
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W-N-L motif   sc451-507 
This motif is much less conserved than the previous ones. However, it contains 
W451, N459, and L473 that are well conserved.  
B motif   sc514-523 
The B-motif (also be called RLK/R motif for residues found in sc518-519) is 
called B due to its presence in hGle1B and not in hGle1A. This motif is interesting since 
it is probably responsible for binding Nup42, the hCG1 homologue in yeast. 
Additionally, the positively charged residues of the RLK/R sequence are only present in 
Gle1 from groups 2 and 3 (see below).  
We can divide Gle1 sequences in three groups: Group1 (B. cinerea, H. 
capsulatum, A. terreus, M. grisea, C. immitis, N. crassa, and A. nidulans), Group 2 (C. 
albicans, S. cerevisiae, C. tropicalis, C. guilliermondii, C. lusitaniae, L. elongisporus, 
and S. pombe), and Group 3 (M. musculus, G. gallus, R. norvegicus, H. sapiens, and D. 
rerio). Group 1 contains a DILA motif but does not contain a complete KKCP motif. 
Instead, they contain a VV, IV, or VS instead of KK. Interestingly, these amino acids are 
required for IP6 in scGle1. Group 2 contains a sequence LNxAKA within the E-A-P 
motif. Additionally, they contain a complete KKCC motif but not a DILA sequence. 
Group 3, corresponding to the Gle1 sequences from higher eukaryotes, contains a DILA-
KKCP motif but lack the LNxAKA sequence in the E-A-P motif.  
Interestingly, several positively charged amino acids are present only in Group 2 
and Group 3 Gle1 sequences. These amino acids include K377, K378, K494, R517, and 
R287. R519 is also present in most Group 2 and 3 Gle1 sequences, but A. nidulans and A. 
terreus Gle1 also contain R519.  
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In order to gain a deep understanding of Gle1/IP6-driven stimulation of Dbp5 
ATPase activity, we require the purification, concentration, and crystallization of Gle1 
and Gle1 domains. We have cloned Gle1 fragments from fungal species that might 
facilitate the rapid purification and concentration of these domains. From S. cerevisiae we 
have cloned C-terminal fragments: sc241-538, sc244-538, sc272-538, and sc435-538. 
From S. pombe we have cloned C-terminal fragments: sp188-479 and sp193-479. From 
N. crassa we have cloned C-terminal fragments: nc283-541 and nc320-541. From A. 
nidulans we have cloned C-terminal fragments: an235-481 and an260-481. Constructs 
were tested for expression in bacteria. All S. cerevisiae and S. pombe fragments 
expressed robustly (Figure B1). Gle1 from N. crassa expressed only in some cases. 
However, none of the A. nidulans clones expressed significant amount of protein. (Figure 
B2). Future goals are to purify and crystallize full length Gle1 protein from yeast or other 
fungal species.  
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C. Yeast strains used in this study 
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 C. Yeast strains used in this study continued 
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C. Yeast strains used in this study continued 
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D. Plasmids used in this study 
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D. Plasmids used in this study continued 
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E. Methods 
 
 
3H-IP6 Binding Assays 
 
General properties:  
 
The total buffer concentration is: 
16 mM HEPES pH 7.5 
120 mM NaCl 
16% Glycerol w/v 
3 mM MgCl2 
1mg/ml BSA 
 
6µl  5X ATPase Buffer A 
18µl  Proteins in Buffer B 
6ul  Waters (3H-IP6/RNA/ATP/etc) 
30ul 
 
• Buffer B: 20 mM HEPES pH. 7.5; 150 mM NaCl; 20% Glycerol w/v 
• 5X ATPase Buffer A: 20 mM HEPES pH 7.5/150 mM NaCl/20% Glycerol 
w/v/ 15 mM MgCl2/1mg/ml BSA   
• Use siliconized tubes (1.5ml) 
• 3H-IP6 21.4 Ci mmol-1; PerkinElmer LAS  
• 30% PEG 3350 filtered 
 
 
1. – Calculate experiments for triplicates for each control and unknown 
 
2.  Make master in this order:  
 
5X ATPase buffer  
Waters (but no IP6) 
Buffer B 
Proteins 
 
3. Aliquot in however many tubes you need. Add to each tube Buffer B and then 
your protein to make a final sample prior to addition of 3H-IP6 
 
4.- Mix well by softly flicking a couple of times and then spinning them down in 
the nanofuge for a few seconds 
 
5.-  Add 3H-IP6 (and/or non-label IP6 and or competitors). 
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Add IP6 with siliconized tip. Mix all samples at the end by passing them 3x times 
through rack, then mix by soft flicking a couple of times and spin in nanofuge. 
 
6.- Let equilibrate for 10min at room temperature  (or longer on the protein) 
 
 
7.- Precipitate by addition of 20ul 30% PEG 3350 (w/v) for a final concentration of 
12% PEG.  
Mix well by flicking till you cannot see any changes in PEG and sample (usually a 
couple of seconds of soft flicking) 
 
8.- Place in centrifuge carefully so that the back of the tube is align with the well. 
Close centrifuge and let it reach 4 ˚C with samples inside (about 10’) – then spin 
for 25’ 
 
9.- Extremely carefully extract all unbound IP6. Be careful not to touch the side of 
the tube where the invisible pellet would be.  
 
10.- Optional steps:  
 
Wash with100ul Buffer B or spin again for 20 sec. and re-aspirate the 1-3 µl 
remaining  
 
11.- Add 300ul 1% SDS. Incubate overnight at room temperature 
 
12.- Resuspend the invisible pellet. Mix and finally pour all 300 µl into a 
scintillation vial with 4ml scintillation fluid 
 
13.- Mix well and count 
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ATPase assay  
 
 
Keep reaction on Ice. I have seen that Dbp5’s ATPase activity on ice is very low, 
but it has some. You start you rxn by addition of Mix3. Time it and stop by putting 
back in ICE and applying STOP MIX as soon as possible.  This is the recipe for 
1rxn of 10ul.  A time course can be done as well just by doing one tube with a 
grater volume.  
 
Reaction components: 
6 µl Protein 
2 µl Waters 
2 µl 5X ATPase buffer 
 
1 Reation 
 
Master Mix1: 
5xATPase Buffer 0.3 µl 
Superasin 20 U/ul 0.5 µl 
H20   0.2 µl 
RNA 20µM  0.5 µl 
   1.5 µl 
 
Master Mix2: 
5xATPase Buffer 1.0 µl 
DTT 100mM  0.1 µl 
Buffer B (protein) 3.4 µl  
IP6 (water)  0.5 µl  
   5.0 µl 
 
Master Mix3: 
5xATPase Buffer 0.7 µl 
Buffer B (protein) 2.6 µl 
ATP 100mM 0.1 µl 
ATP 32P  0.1 µl 
   3.5 µl 
 
Aliquot and Mix 1 and Mix2 in order shown. 
Mix well and spin down. 
Start reaction with addition of Mix3 (if dealing with one sample) or by quickly 
adding Mix3 to a number of samples (in plastic float) and simultaneously passing 
them all from ICE to the 30 ˚C water bath and starting a timer. 
 
Reactions are carried out at 30 ˚C  or 37 ˚C.  
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Linear ATPase activity lasts for about 13 or 15 minuntes when using 500 nM 
Dbp5 and 250 nM Gle1.  
 
At the end of reaction stop with 2ul stop buffer: (50 mM Tris pH 7.4; 5 mM EDTA; 
1.5% SDS; 2mg/ml Proteinase K (Ambion)) 
 
Incubate at 37 ˚C x 30min 
Place on ice. 
 
Label Baker Flex Cellulose PEI thin layer chromatography plates (J. T. Baker). 
Spot 2ul of stopped reaction on TLC plates (1 inch from bottom and at least 
1.25cm from each other). 
 
Make up a solution of 0.6 M potassium phosphate pH 3.4. Fill TLC tank with 
330ml. Run TLC. Note - Make sure TLC sheet is dry and buffer in the wall of the 
TLC tank does not touch TLC sheet. 
 
Run chromatography for ~5 hrs. Dry and expose for 30 min. or 1 hr. (Depending 
of the strength of signal. 
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